Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jan 3;19(1):e0294739. doi: 10.1371/journal.pone.0294739

Seatbelts and raincoats, or banks and castles: Investigating the impact of vaccine metaphors

Stephen J Flusberg 1,*, Alison Mackey 2, Elena Semino 3
Editor: Wojciech Trzebiński4
PMCID: PMC10763949  PMID: 38170715

Abstract

While metaphors are frequently used to address misconceptions and hesitancy about vaccines, it is unclear how effective they are in health messaging. Using a between-subject, pretest/posttest design, we investigated the impact of explanatory metaphors on people’s attitudes toward vaccines. We recruited participants online in the US (N = 301) and asked them to provide feedback on a (fictional) health messaging campaign, which we organized around responses to five common questions about vaccines. All participants completed a 24-item measure of their attitudes towards vaccines before and after evaluating the responses to the five questions. We created three possible response passages for each vaccine question: two included extended explanatory metaphors, and one contained a literal response (i.e., no explanatory metaphors). Participants were randomly assigned to receive either all metaphors or all ‘literal’ responses. They rated each response on several dimensions and then described how they would answer the target question about vaccines if it were posed by a friend. Results showed participants in both conditions rated most messages as being similarly understandable, informative, and persuasive, with a few notable exceptions. Participants in both conditions also exhibited a similar small—but significant—increase in favorable attitudes towards vaccines from pre- to posttest. Notably, participants in the metaphor condition provided longer free-response answers to the question posed by a hypothetical friend, with different metaphors being reused to different extents and in different ways in their responses. Taken together, our findings suggest that: (a) Brief health messaging passages may have the potential to improve attitudes towards vaccines, (b) Metaphors neither enhance nor reduce this attitude effect, (c) Metaphors may be more helpful than literal language in facilitating further social communication about vaccines.

Introduction

The novel coronavirus pandemic claimed nearly seven million lives worldwide in the first three years. This outcome could have been much worse if not for the development of safe and effective vaccines that greatly reduced the risk of dying from COVID-19. While governments across the globe worked to make vaccines widely accessible—and, in many contexts, mandated their use—these efforts were accompanied by a vocal backlash and an outpouring of anti-vaccination sentiment. This resistance was not a surprise for some observers. The World Health Organization (WHO) had named”vaccine hesitancy” one of the top threats to global health in 2019 [1], months before the pandemic would take hold.

Vaccine hesitancy is a complex phenomenon [2]. It has been associated with many factors, including age, education, mistrust in institutions, engaging with misleading sources online, local and sometimes vaccine-specific personal/family histories [3], and”folkloric narratives” [48]. A 2014 WHO report from the Strategic Advisory Group of Experts on Immunization (SAGE) includes three categories of determinants of vaccine hesitancy [9]: (a) “contextual influences” (e.g., religion, culture, politics, media environment); (b) “individual and group influences” (e.g., previous experiences with vaccinations by the individual and their kinship and social groups, immunization as a social norm or as not needed or harmful); and (c) “vaccine/vaccination-specific issues” (e.g., new vaccine, mode of administration, cost, risks vs. benefits). Responding to vaccine hesitancy is, therefore, likewise a complex enterprise that goes beyond the provision of ‘accurate’ information [10], whether in public health campaigns or interactions between healthcare providers and individuals. In this context, then, it is important to investigate the utility of different approaches to vaccine-related communications. The current study investigates the effectiveness of explanatory metaphors in public health messaging about vaccination and their influence on how individuals perceive and communicate about different aspects of vaccinations with members of their own social groups.

Metaphor in communication and thought

Metaphor has been regarded as an important tool for persuasion and explanation since classical antiquity. Over the last 50 years, scholars from multiple disciplines have studied the role of metaphor in communication and thought using a broad range of methods. The seminal work by linguist George Lakoff and philosopher Mark Johnson has proven especially influential in this pursuit. They famously proposed that conventional metaphors in language (e.g., “She shot down all my arguments”) are realizations of conceptual metaphors in thought (e.g., argument is war; [11]). In other words, people don’t just speak metaphorically; they think metaphorically.

According to Lakoff and Johnson’s ‘Conceptual Metaphor Theory’ (CMT), we understand a target domain (e.g., argument) by importing knowledge and structure from a source domain (e.g., war). In this way, people can leverage their knowledge of familiar subjects to reason about novel or complex subjects. The choice of source domain influences how the target domain is conceptualized, resulting in potential “framing effects” of metaphors. This is because metaphors have unique entailments; the structure of the source domain facilitates certain inferences—but not others—when it is mapped onto the target domain. For example, if an argument is understood metaphorically as a war, then the goal of interactants is to win—to ensure that one’s own views prevail. If an argument is understood metaphorically as a journey, in contrast, then the goal of interactants may be to meet in the middle—to find a compromise. Lakoff and Johnson argued that human thought is largely organized in this way and that reasoning about abstract domains is virtually impossible without metaphors [11].

Discourse analysts have, in some cases, found Lakoff and Johnson’s notion of the conceptual domain too broad to explain how metaphors are used in discourse, especially in the context of explanation and persuasion. In a series of studies on political discourse, Musolff [12, 13] has employed the sub-domain notion of scenario as a “a set of assumptions made by competent members of a discourse community about ‘typical’ aspects of a source-situation, for example, its participants and their roles, the ‘dramatic’ storylines and outcomes, and conventional evaluations of whether they count as successful or unsuccessful, normal or abnormal, permissible or illegitimate, etc.” [12, p. 28]. In this way, the same overarching domain may generate different conceptual entailments under difference domain-related scenarios. For example, in a study of metaphors in cancer experience, Semino et al. [14] showed how war-related metaphors can have different implications (e.g., for the (dis)empowerment of patients) depending on the specific scenario involved, such as preparing for battle (e.g., “I am sharpening my weapons in case I have to do battle”) vs. outcome of battle (e.g., “I’m not winning this battle”).

While there are ongoing debates over CMT and the cognitive mechanisms that support metaphor processing, there is a general consensus that metaphors play a critical role in communication and cognition [1518]. Over the past decade, for example, a large body of experimental research has shown that metaphors can enhance the persuasive power of messaging and explanations (for review, see [17, 18]). Using a metaphor to convey a complex issue like climate change [19], crime [20], cancer [21, 22], or the federal budget [23] can shape observer beliefs and attitudes in ways that are compatible with the metaphor’s entailments.

The impact of framing a concept with a metaphor has been studied in a variety of ways. This includes having participants who have received information via metaphor provide or select a solution to a problem [20, 24], express their behavioral intentions [19, 21], and indicate their beliefs, preferences, or emotional states [22, 23, 53]. Table 1 provides a summary of variables that have been shown to moderate metaphor framing effects. This work has provided rich insights into the cognitive, affective, and social-pragmatic factors that influence the potency of metaphorical messages (see [17, 18] for reviews).

Table 1. Variables that moderate the impact of metaphor framing.

Variable Findings References
Source domains Metaphors are more likely to have an influence if they involve source domains that are accessible, well-delineated, and image-rich. [17, 18, 53]
Target domains Metaphors are more likely to have an influence if they involve target domains that are neither too unfamiliar/uninteresting for people nor overly linked to strong prior beliefs and evaluations. [17, 18]
Structural alignment between source and target domain Metaphors are more likely to have an influence if they involve precise and clearly applicable mappings, i.e., when they are ‘apt’. [17, 23]
Textual position Metaphors are more likely to have an influence if they are presented early rather than late in a text. [20]
Extension Metaphors are more effective when they are extended. [2527]
Conventionality/creativity Metaphors are more likely to be appreciated and found meaningful if they are conventional or moderately innovative as opposed to highly innovative, likely because radically novel metaphors can be difficult to understand and harder to appreciate. [28, 29]
Participant characteristics The influence of metaphors varies depending on how much the source domain resonates with the individual, their political affiliation, and cultural background; for example, strong prior beliefs can mitigate the impact of a metaphorical message. [24, 3032]

Explanatory metaphors in vaccine discourse

Health communicators have developed a range of metaphors to address common questions and misconceptions about vaccines. These healthcare metaphors are often extended, elaborated, and used to provide explanations with the goal of persuasion. They contrast with the more subtle metaphoric language studied in most research on metaphor framing described above (although see [23] for an exception).

Recently, for instance, a range of metaphors have been deployed by scientists and healthcare practitioners to explain why people should get the COVID-19 vaccine even though it does not offer complete protection from the virus. For example, the US-based Northeast Georgia Health System published a blog post in 2021 titled “How is the COVID-19 Vaccine like a Seatbelt? [33]. As the blog post reminds the reader, wearing a seatbelt keeps you safe in the event of an accident, but it is still possible to get hurt. This is also the case with vaccines for COVID-19. A similar idea is conveyed by the metaphor vaccines are raincoats, used, for example, in the following representative X post (formerly called Twitter) by a scientist in July 2021 [34]: “Concerning breakthrough infections. Think of the vaccine as a very effective raincoat. If it’s drizzling, you’ll be protected. If the rain is coming down hard, you might still be fine. But if you are going in and out of rainstorms all the time, you could end up getting wet.”

Another common question about the COVID-19 vaccines is how they were developed so quickly—and whether this means they are not as safe as vaccines that were developed more slowly in the past. Professor Sarah Gilbert and Dr. Catherine Green used a vivid metaphor to address this concern in their book Vaxxers about the development of the Oxford AstraZeneca vaccine [35]. They ask the reader to consider how a baker might speed up the process of producing cakes with personalized messages (p. 66):

“Think about a baker who sells personalised cakes iced with a message like ‘Happy 50th birthday Joe’ or ‘Congratulations on your engagement Ali and Max’. She might wait until she gets an order, and only then start the process of mixing the ingredients, baking the cake, letting it cool, icing it all over, waiting for the icing to set, and then finally adding the customized message. If she gets the order the day before the cake is needed, that works well. But if she wants to be able to offer a quicker service, she could bake a stock of cakes and put on the base layer of icing every morning. She is taking a financial risk: if no orders come in, the pre-baked cakes will go stale and need to be thrown away. But it may be worth the risk. When a customer comes into the shop, all she has to do is pick up her piping bag and add the custom message while he waits. The cake is then ready to take straight to the party. Only in the case of a vaccine, the party is a pandemic.”

In this metaphor, the cake represents the starting material needed to develop any generic vaccine. The personalized icing represents the pathogen-specific string of DNA that is added to create a pathogen-specific vaccine. As the authors explain, researchers working on COVID-19 vaccines had pre-baked a stock of cakes that could be quickly iced when the novel coronavirus was decoded. Baking each personalized cake from scratch when the order is placed, on the other hand, reflects the older, less efficient method for developing vaccines.

The authors use another food-based metaphor to supplement their explanation. Before the COVID-19 pandemic led governments worldwide to invest enormous sums into vaccine research, funding this work was a slow and arduous process that required a lot of bureaucratic red tape (p. 157): “It is as if you are making a roast dinner and for every ingredient you have to make a separate trip to the shops to buy it, then cook it and demonstrate that it is going to be delicious, before moving on to the next.” When COVID-19 hit and governments infused this sector with substantial funding, on the other hand, “We were allowed to do a big shop and put all the ingredients we needed in the trolley all at once” (p. 158).

There has been limited research on the impact of metaphor framing on vaccine attitudes [36, 37]. In one such study, Scherer and colleagues [36] investigated whether describing influenza metaphorically (as a beast, riot, army, or weed) would increase people’s willingness and interest in being vaccinated. They found that, compared to a comparable literal description, metaphorical descriptions of the flu increased people’s expressed willingness to be vaccinated. This effect was observed more consistently in people who occasionally got the flu vaccine compared with those who never got it. Their study highlights one variable—the strength of prior beliefs or attitudes—that moderated the impact of a metaphoric message (as shown in Table 1, for example). Describing the influenza virus as a beast is quite different from the elaborate explanatory metaphors used in COVID-19 discourse, however. For one thing, beast is a metaphor for a virus rather than a metaphor for some aspect of vaccination. For another, beast is a subtle, one-off metaphor rather than an extended and elaborated explanatory metaphor. In contrast, the cake metaphor described above is explicitly presented as an explanation for how researchers could develop the COVID-19 vaccines so quickly, and it was extended and developed throughout the text. It is this latter type of explanatory metaphor that we aimed to evaluate in the present study.

A recent study by Ervas and colleagues [37] did examine how an explanatory metaphor would impact the efficacy of vaccine communications. Their central message focused on “collective immunity,” emphasizing how all people should be required to receive a vaccination to benefit the larger group. Including an explanatory metaphor—likening people to bees in a beehive who must collaborate—significantly increased a range of assessments of the message, including its emotional impact and perceived convincingness. However, it did not increase intentions to vaccinate. Our study builds on this basic design by sampling a wider range of more elaborate explanatory metaphors in vaccine discourse and using a more comprehensive measure of general vaccine attitudes.

The current study

A critical question concerns the general effectiveness of extended explanatory metaphors in vaccine discourse. That is, do such metaphors lead to positive effects on people’s understanding of and attitudes towards vaccination? To date, this issue has not been systematically assessed in the experimental literature. We addressed this question in the current study by comparing the outcomes of participants of health messages with and without extended explanatory metaphors.

Methods

Overview

We used a between-subject, pretest/posttest design. Participants completed a 24-item measure of their attitudes towards vaccines both before and after evaluating health messages that we organized as a series of responses to five common questions about vaccines. We created three responses for each question: two responses included unique explanatory metaphors—adapted from real-world source materials like the ones described above—and a baseline response that provided the same information but did not include an explanatory metaphor. We refer to these baseline responses as ‘literal’ responses, and we operationalized this term as “not containing an extended explanatory metaphor.” Participants were randomly assigned to receive either all metaphor or all literal messages. Those in the metaphor condition randomly received one of the two explanatory metaphors in response to each of the five target questions. After reading each response, metaphor and literal participants rated how understandable, informative, and persuasive it was. This allowed us to measure whether people interpreted metaphor-infused messages as more effective, equally effective, or less effective when compared to literal messages (i.e., those that were not organized around a central explanatory metaphor). We also included an innovative method for assessing the impact of metaphorically framed messages: after rating each message, participants were asked to freely describe how they would answer the associated target question if it were posed to them by a friend. This resulted in a rich natural language dataset that allowed us to conduct novel linguistic analyses to assess the impact of metaphors.

Our findings provide important insights into the effects of explanatory metaphors in vaccine communications. The study also serves as a design model for the systematic investigation of the role of explanatory metaphors in public discourse, as we included a combination of traditional quantitative and linguistic analytic methods.

Participants

Data were collected in June 2022. We recruited 301 participants from Amazon’s Mechanical Turk crowdsourcing platform [38]. We used the CloudResearch interface [39], which includes a set of pre-screening measures shown to improve Mturk participant and data quality [40, 41]. We aimed for a sample size of at least 100 individuals in each condition to be consistent with past research on metaphor framing [e.g., 17, 25, 42, 43]. All participants were at least 18 years of age (M = 38.3, SD = 10.4), residents of the United States, and had a good performance record on previous MTurk tasks (with a minimum of 95% approval rating). The sample included 117 female, 176 male, and four non-binary/no-gender participants, with four additional participants who preferred not to indicate their gender. We did not collect information that could identify individual participants during or after data collection. All participants gave informed consent prior to beginning the study. This study was reviewed and approved under reference FASSLUMS-2021-0576-RECR-2 by Lancaster University Management School Research Ethics Committee’s Faculty of Arts and Social Sciences (FASS-LUMS). Participants were paid $3 (USD) once they completed the study.

Materials

Vaccine Attitude Measure (VAM)

We developed a 24-item questionnaire designed to measure participants’ beliefs and attitudes toward vaccines. Most items were adapted from (a) the Vaccination Attitudes Examination Scale [44], (b) the Vaccine Hesitancy Scale [45], and (c) the Vaccine Conspiracy Beliefs Scale [46]. We also included (d) unique items generated for the purposes of the current study. We drew on multiple sources to create a comprehensive measure that addressed a wide range of vaccine beliefs and attitudes. Items were clustered into eight sub-categories consisting of three items each, as illustrated in Table 2. The instructions required participants to indicate their support for a series of statements on a scale from 1 (strongly disagree) to 7 (strongly agree). Tests of internal consistency showed the measure was reliable (Cronbach’s α = 0.937 for the VAM pretest). In coding, we averaged together responses, reverse-coding as needed, such that higher scores equate to more positive attitudes and more accurate beliefs about vaccines.

Table 2. Items, coding, and sub-categories in our Vaccine Attitude Measure (VAM).
Item Sub-Category
Vaccines are effective at preventing serious illness How vaccines work
Vaccines are designed to target and neutralize viruses that enter the body (I)a
Vaccines contain new antibodies designed to deal with infections (I)a
Natural immunity is better than immunity achieved through vaccination (I)a Natural immunity
Natural exposure to viruses and germs gives the most effective protection (I)a
Being exposed to diseases naturally is safer for the immune system than being exposed through vaccination (I)a
Each new disease requires that a new vaccine be made from scratch (I)a Speed of vaccine development
Vaccines that are developed quickly cannot be trusted (I)a
Newer methods allow safe vaccines to be developed more rapidly than in the past
Only people who are at risk of serious illness should get a vaccine (I)a Personal versus community risk
Vaccines only impact the individual who gets the vaccine (I)a
Getting vaccinated is important for the health of others in my community
Vaccines that do not fully prevent infections are ineffective (I)a Why vaccinate if not 100% effective
If a vaccine requires multiple doses or boosters, it means the vaccine isn’t effective (I)a
Vaccines prevent you from spreading a virus to other people (I)a
I do not have concerns about getting vaccinated Personal attitudes towards vaccines
I can rely on vaccines to stop me from getting seriously ill from an infectious disease
I feel protected after getting vaccinated
Immunizing children is harmful, and this fact is covered up (I)a Attitudes toward childhood vaccinations
Childhood vaccines are important for public health
Getting vaccines is a good way to protect children from disease
The government is trying to cover up the link between vaccines and autism (I)a Vaccine conspiracy beliefs
Pharmaceutical companies cover up the dangers of vaccines (I)a
Vaccine efficacy data is often fabricated (I)a

a “I” indicates a reverse-coded item.

Vaccination questions and messages

We designed the stimulus materials to resemble a public health messaging campaign. To identify common misperceptions, we focused on public health messaging in the U.S., the U.K., and other international organizations. This included, for example, the comprehensive Myths and Facts about COVID-19 Vaccines from the Centers for Diseases Control in the U.S. [47], Vaccine Myths from the British Society for Immunology [48], and Vaccines and immunization: Myths and Misconceptions from the World Health Organization [49]. We focused on five questions aimed at tapping into common questions, misconceptions, and concerns about vaccines, as follows:

  1. How do vaccines work?

  2. Is ‘natural immunity’ better than the immunity provided by a vaccine?

  3. Are vaccines that are developed quickly safe?

  4. Why should I take a vaccine if I am personally at low risk for the illness?

  5. Why get a vaccine if it isn’t 100% effective?

For each question, we created three corresponding responses: two that used extended explanatory metaphors that were different from each other and a baseline literal response that, as we noted earlier, did not include an extended, explanatory metaphor. Using Musolff’s [12] terms, these extended metaphors exploit the narrative potential of specific source scenarios. Most of the metaphors were adapted from authentic, real-world examples of metaphors in common use in vaccine discourse. These were collected through the authors’ observations from the media and from websites on public health messaging, like those listed above and described in the Introduction. We computed readability consensus scores to ensure comparability of the texts based primarily on the work of Flesch and Flesch-Kincaid and others [50], using a range of measures to gauge the readability or difficulty level of a text in English. These explanatory messages are provided in Table 3.

Table 3. Vaccination questions and corresponding explanation stimuli.
Question 1: How do vaccines work?
Metaphor 1: Castle To understand the reason for vaccinations, it’s important to understand how vaccines work. Vaccines enable your immune system to do two things: (1) stop you getting infected by viruses or, (2) if you do get infected, end the infection itself because of the help your immune system has had from the vaccine. You can picture your body as a medieval castle. The castle is surrounded by an army of viruses trying to break in and take over. Your body’s first line of defense is an outer wall patrolled by a group of archers. These are your immune system’s antibodies. If they can hold the viral army off, then you won’t get infected. But if the antibody archers are overwhelmed, then the virus can break through. Once the virus is in the castle, you have an infection. However, all is not lost. You still have elite troops inside the castle. These are your memory B and memory T cells. If your outer walls are breached, these elite cells are inside ready to lead the charge and repel the hostile invaders. Vaccines train your body’s troops, including both the archer-antibodies and the inner cell warriors that react to an infection. However, the antibodies that patrol the outer wall sometimes forget their training. That is when the vaccine’s effectiveness wanes, and you may be infected even if you had previously been vaccinated. But the memory cells inside the inner castle are still there and can get organized very quickly to repel any invaders who have entered the castle. That is when a vaccine protects you from serious illness and death, even if not from infection. For viruses that won’t go away or that even change over time, boosters can strengthen your defending army. Boosters not only ensure there are enough archers in position defending the outer wall, they also provide the elite troops inside the inner castle with updated weapons training so that they are prepared to take on any potential invaders. The archers and troops might still be able to do their job without boosters. However, since boosters typically contain updated information about the virus’ new strengths and weaknesses, the archers and troops who face the infection without boosters are disadvantaged, with fewer resources and less knowledge than those who received the vaccine booster.
Metaphor 2: Bank To understand the reason for vaccinations, it’s important to understand how vaccines work. Vaccines enable your immune system to do two things: (1) stop you getting infected by viruses or, (2) if you do get infected, end the infection itself because of the help your immune system has had from the vaccine. You can picture your immune system as the high-quality security measures surrounding a bank. The first line of protection from burglars is the security cameras monitoring the doors and windows. These are your immune system’s antibodies. If they detect the burglars and trigger the alarm, then you won’t get infected. But if any of the cameras fails, then the virus can get in. You now have an infection. Any cash stored in the bank could quickly be stolen. However, all is not lost. You still have a team of security guards inside the bank. These are your memory B and memory T cells. If the bank is broken into, they are ready to lead the immunological charge to stop the burglars. Vaccines train your body’s security-measures, including both the security camera antibodies and the inner cell guards that react to an infection. However, cameras can fail if they have not been updated for some time. That is when the vaccine’s effectiveness wanes, and you may be infected even if you had previously been vaccinated. But the team of security guards is still there to deter an infection and can get organized very quickly to chase the burglars away before they steal the valuables in the bank. That is like when a vaccine protects you from serious illness and death even though it doesn’t protect you from the initial infection. For viruses that won’t go away or that even change over time, boosters can upgrade the bank’s security measures. Boosters not only ensure the camera systems are up-to-date, but also provide the security guards inside the bank with new training and equipment so that they are prepared to repel any burglars. The camera systems providing outer-defense and the guards providing inner-defense may technically still be able to complete their responsibilities without boosters. However, since boosters typically contain updated Information about the virus’ new strengths and weaknesses, the security systems and trained guards who have to face the infection without boosters are at a disadvantage with fewer resources and less knowledge than those who received the vaccine booster.
Literal To understand the reason for vaccinations, it’s important to understand how vaccines work. Vaccines enable your immune system to do two things: (1) stop you getting infected by viruses or, (2) if you do get infected, end the infection itself because of the help your immune system has had from the vaccine. One important factor in stopping infections is the presence of antibodies. If you have them in sufficient numbers, then you won’t get infected. But if you don’t have enough antibodies, the virus can start replicating in your cells and you get an infection. However, all is not lost. There are still your memory B and memory T cells. They can eliminate the infection in your body so that you recover without getting very sick. Vaccines enable your body to develop both the antibodies that help prevent infection and also the memory cells that can react to a potential infection. However, the antibodies decrease in number over time. As they decrease, the vaccine’s effectiveness wanes, and you may become infected even though you’ve been vaccinated. However, your memory B and T cells last much longer, and are always ready to deal with an infection. This is how a vaccine prevents serious illness and death even when it doesn’t prevent infection. For viruses that won’t go away or that even change over time, boosters can both increase the number of antibodies again as well as strengthen the memory cells in case they are needed.
Question 2: Is “natural immunity” better than the immunity provided by a vaccine?
Metaphor 1: Pilot Vaccines help your body build up immunity safely without the risks associated with a viral infection. In this way, vaccines are like the flight simulation programs that airplane pilots are trained on before they attempt to fly a plane through bad weather conditions. This training allows pilots to practice flying through (simulated) bad weather in a safe environment, helping them become better pilots in real life later on. In the same way, vaccines help to train your immune system to handle a virus without the risks associated with a real infection. When an untrained pilot encounters bad weather for the first time while actually flying, they may be able to figure out how to get through it without crashing the plane, and having that experience would help them fly in bad weather better in the future. However, there’s always more risk of crashing when pilots have no prior training. Similarly, there is always more risk that a person can become very ill from an infection if they have no prior immunity. In other words, immunity can be achieved either by being infected with a virus or by being vaccinated against it. However, with vaccines there is little risk of serious illness in this process.
Metaphor 2: Fire Drill Vaccines help your body build up immunity safely without the risks associated with a viral infection. In this way, vaccines are like the fire drills that students do in schools. These drills allow them to practice what they would do in a fire emergency but in a safe environment, so they would be better able to handle a real fire if one occurred. In the same way, vaccines help train your immune system to handle a virus without the risks associated with a real infection. If untrained students experience a fire in the classroom, they may be able to figure out how to get through it without getting injured, and this experience would help them survive a similar fire in the future. However, there’s always more risk of panicking and getting seriously hurt in fire situations without training. Similarly, there is always more risk that a person can become very ill from an infection if they have no prior immunity. In other words, immunity can be achieved either by being infected with a virus or by being vaccinated against it. However, with vaccines there is little risk of serious illness in this process.
Literal Vaccines help your body build up immunity safely without the risks associated with a viral infection. If an unvaccinated person recovers from a viral infection, their immune system may be able to protect them from similar viruses in the future. However, there is always a risk that a person might become very ill from the actual infection because they have no prior immunity. In other words, immunity can be achieved either by being infected with a virus or by being vaccinated against it. However, with vaccines there is little risk of serious illness in this process.
Question 3: Are vaccines that are developed quickly safe?
Metaphor 1: Cake Scientists are now able to develop vaccines much more quickly than in the past. Why is this? Think about a baker who sells personalized cakes with messages like ‘Happy 50th birthday, Taylor!’ or ‘Congratulations on your new job, Sam!’. The baker might wait until they receive an order, and only then start the baking process from scratch, mixing the necessary ingredients, baking the cake, letting it cool, making the icing, and finally adding the customer’s personalized message. But this is a slow process. For a much more efficient service, bakers can make a batch of cakes ahead of time, and when a customer comes into the shop, they can ice the personalized message onto the pre-made cake. In a shorter amount of time, the personalized cake Is ready. In the same way, today’s scientists do not start inventing vaccines from scratch when a new virus comes along. After many years of research and testing they have developed a vaccine-base, like a generic cake. When a new virus emerges, they quickly get the information they need to adapt the vaccine to the virus, which Is like adding messages on the cake. This new vaccine is immediately ready to be tested before being rolled out to the public.
Metaphor 2: Video Game Scientists are now able to develop vaccines much more quickly than in the past. Why is this? Think about the companies that produce video games. Rather than creating a brand-new video game each time players ask for new features like storylines, characters, or gameplay modes, companies can meet their players’ wishes by releasing updates to pre-existing games that can be downloaded to players’ existing consoles. The developers simply write a piece of new code. They can then release game updates or patches that add these new features to their pre-existing video games, allowing players to continue playing their game with the latest features, all without needing to develop a brand-new game from scratch. These updates and patches with new game features are alterations to the original base program that can easily be tested and refined before finally being released to the public. In the same way, today’s scientists do not start inventing vaccines from scratch when a new virus comes along. They have already developed an existing vaccine-base after many years of research and testing. When a new virus emerges, they quickly get the information they need to adapt the vaccine to the virus, which is like updating their base with the necessary and latest features. This new vaccine is immediately ready to be tested before being rolled out to the public.
Literal Scientists are now able to develop vaccines much more quickly than in the past. Why is this? Nowadays, scientists do not start inventing vaccines from scratch when a new virus comes along. After many years of research and testing, they have developed generic technologies and platforms that can be used and adapted to fit any virus. When a new virus emerges, scientists quickly get the information they need to adapt the generic platform and create a new vaccine that is immediately ready to be tested before being rolled out to the public.
Question 4: Why should I take a vaccine if I am personally low-risk for the illness?
Metaphor 1: Speed Limit With certain viruses, some people who get infected experience only minor symptoms while others can get very sick or even die. When there is uncertainty with new viruses, however, everyone is invited to get vaccinated, regardless of their own personal risk level. Likewise, speed limits apply equally to all drivers and vehicles. Even though different vehicles have different safety features for occupants, it doesn’t make sense to allow some people to drive faster based on the safety features of their personal vehicle. This is because, even though some drivers might at lower risk of personal injury because of their vehicle’s safety features, those drivers would still be a danger to other drivers on the road. In the same way, unvaccinated low-risk people may be less likely to be harmed by a virus, but they are still a danger to people who are more likely to be made very ill by the virus.
Metaphor 2: War With certain viruses, some people who get infected can experience minor symptoms while others can get very sick or even die. When there is uncertainty with new viruses, however, everyone is invited to get vaccinated, regardless of their own personal risk level. Likewise, when a country is attacked in war, its leaders mobilize people, weapons, and resources from throughout the different regions of the country to defend it. This is because, even though some regions are low-risk, meaning less vulnerable to attack than others, it wouldn’t make sense to exempt them from contributing, because cooperation across regions makes it more likely the country can repel the invaders. In the same way, unvaccinated low-risk people may be less likely to be harmed by a virus, but they can support the health of entire population by getting vaccinated, which helps the nation fight off the virus and reduces the chances of high-risk people becoming ill.
Literal With certain viruses, some people who get infected experience minor symptoms while others can get very sick or even die. When there is uncertainty with new viruses, however, everyone is invited to get vaccinated, regardless of their own personal risk level. This is because, if low-risk people are unvaccinated, they may still infect other people who are more likely to be made very ill by the virus. So, unvaccinated people can be a danger to others, even if the chance of them becoming very ill is small.
Question 5: Why get a vaccine if it isn’t 100% effective?
Metaphor 1: Raincoat Being vaccinated is an effective way of reducing your chances of being infected with a virus, just like wearing a waterproof raincoat during a storm reduces your chances of becoming wet. However, even the best raincoats don’t provide 100% protection from getting wet. In the same way, vaccines don’t provide 100% protection from a virus, and it is still possible to become sick even after you have been vaccinated and given a booster. For example, you could get sick if you are exposed to a large amount of the virus in your daily life, which is like going out during a severe rainstorm. You could also get sick if the immune reaction caused by the vaccine has not been strong or if a new variant develops that partly evades the vaccine. This is like a raincoat not fitting you well. Also, the effects of the vaccine might wane eventually, just like a raincoat might fray, develop holes, and wear out over time. For these reasons, when there are high infection rates in your area, it is still important to take additional precautions even after vaccination. These include avoiding crowded indoor spaces (as you would avoid severe rainstorms) and wearing a face mask (like using an umbrella even though you are also wearing a raincoat).
Metaphor 2: Seatbelt Being vaccinated is an effective way of reducing your chances of being infected with a virus, just like wearing a seatbelt reduces your chances of getting injured in a car crash. However, even the best seatbelts don’t provide 100% protection from getting hurt. In the same way, vaccines don’t provide 100% protection from the virus, and it is still possible to become sick even after you have been vaccinated and given a booster. For example, you could get sick if you are exposed to a large amount of the virus in your daily life, which is like spending a lot of time in heavy, fast traffic. You could also get sick if the immune reaction caused by the vaccine has not been strong or if a new variant develops that partly evades the vaccine. This is like a seatbelt not fitting you well. Finally, the effects of the vaccine might wane eventually, just like a seatbelt might become less effective due to age and wear and tear. For these reasons, when there are high infection rates in your area, it is still important to take additional precautions even after vaccination. These include avoiding crowded indoor spaces (as you would avoid reckless driving) and wearing a face mask (like driving a car with airbags even though you are also wearing a seatbelt).
Literal Being vaccinated is an effective way of reducing your chances of being infected with a virus. However, vaccines do not provide 100% protection, and it is still possible to become sick even after you have been vaccinated and had a booster. For example, you could get infected if were exposed to a large amount of a virus in your daily life. You could also get infected if the immune reaction caused by the vaccine has not been strong, or if a new variant develops that partly evades the vaccine. Finally, the effects of the vaccine might wane eventually. For these reasons, when there are high infection rates in your area, it is still important to take additional precautions even after vaccination, like avoiding crowded indoor spaces and wearing a face mask.

After reading one of the three explanations associated with a particular question, participants were asked to consider how the general public would react to the message and to keep this in mind while responding to four questions. Participants were asked to consider the general public in order to reduce any reluctance they might have to go on the record with their personal responses given the highly emotive and politicized nature of vaccine/booster discourse at the time of the study, as well as to reduce any potential audience effect. In other words, the goal was to obtain maximally authentic data. First, participants rated three properties of the message using a 7-point scale: (1) “How understandable was this paragraph?” (1 = very difficult to understand, 7 = very easy to understand); (2) “How informative was this paragraph?” (1 = not informative at all, 7 = very informative), and (3) “How persuasive was this paragraph?” (1 = not persuasive at all, 7 = very persuasive). Finally—advancing a new methodology for metaphor research and mindful of the influence of social networks on vaccine attitudes—we asked participants how they would respond to a friend who asked them one of the five common questions above about vaccines (e.g., Question 5: “Why get a vaccine if it isn’t 100% effective?”), and to provide the response they would give their friend by typing into a blank text box.

Additional measures

Participants completed two additional measures that pilot testing had revealed to be predictive of attitudes towards vaccines. These measures were, first, the Generic Conspiracist Beliefs (GCB) Scale, which is a 15-item measure of belief in generic conspiracy theories [51]. Examples include “The government is involved in the murder of innocent people and/or well-known public figures and keeps this a secret” and “Technology with mind-control capacities is used on people without their knowledge.” We fine-tuned some of the language in the statements to enhance readability and ensure that the measure could be better understood and applied to participants outside the U.S. in the future. Participants rated the degree to which they believed each item was true on a scale from 1 (definitely not true) to 5 (definitely true). The measure had reliable internal consistency (Cronbach’s α = 0.956) and was coded by averaging all responses such that higher scores equate to a stronger belief in generic conspiracies.

We also used a second scale, the Trust in Institutions Scale (TIS), which was adapted from recommendations provided by the Organization for Economic Cooperation and Development [52]. On this scale, participants rate how much they personally trust the government, the media, the education system, public health officials, political parties, and scientists on a scale from 0 (do not trust at all) to 6 (complete trust). The measure had reliable internal consistency (Cronbach’s α = 0.905) and was coded by averaging all responses such that higher scores equate to greater trust in institutions.

Demographics questionnaire

Participants were asked to provide their age, gender, race/ethnicity, highest level of education achieved, and approximate household income, all using fill-in-the-blank text boxes. Participants were invited to leave the text box blank if they preferred not to provide a response. Participants were also asked to self-report their mathematics and science background using a 4-point scale (1 = no background, 2 = not much background, 3 = some background, 4 = a lot of background, following [48]). A few participants selected two adjacent points on the scale (e.g., 3 = some background and 4 = a lot of background), which led us to score them using the mean of the two points (i.e., 3.5 in the example). Participants also provided their political beliefs using a 7-point scale from 1 (very liberal) to 7 (very conservative). Finally, participants were asked to provide their COVID-19 vaccination status (“Have you had, or do you plan to get, a COVID-19 vaccination?” with response options Yes, No, and Prefer not to say), COVID-19 booster status, (“Have you had, or do you plan to get, a COVID-19 booster vaccination?” with response options Yes, No, and Prefer not to say), and their attitude towards vaccines in general (7-point scale from 1 = strongly opposed to vaccines to 7 = strongly in favor of vaccines).

Procedure

Attention check

Participants first completed an attention check measure embedded in a paragraph ostensibly about how they would prefer to receive information about the study (“[…] Thus, in order to demonstrate that you are a participant who reads the study instructions carefully and thoroughly, you need to check the option “Other” below and enter the number 8 in the text box for this option”). Participants who answered incorrectly were thanked for accessing the survey but were unable to proceed with the study. Participants who answered correctly were directed to complete an informed consent form and proceed with the study.

Instructions

First, participants were told we were “interested in how people understand and react to public health messages” and that they would “read a series of excerpts from a non-partisan public health campaign about vaccines” and provide feedback about each message. They were also asked to complete the survey in one sitting without any breaks. Next, they completed the Vaccine Attitude Measure (VAM pretest). The order of the statements was randomized. This was followed by the vaccine questions and message stimuli. Participants received all five vaccine questions with their corresponding response questions in order from one to five, presented sequentially on separate screens. One-third of participants were randomly assigned to receive the literal messages for all five questions. The other two-thirds of participants were randomly assigned to receive one of the two metaphorical messages for all five questions. The specific metaphorical message they received for each question was randomly drawn from the two options. Next, participants completed the two additional measures (GCB scale and TIS) and the demographics questionnaire. Finally, they were debriefed, thanked for their time, and provided with the contact information for one of the authors. Participants took approximately 19 minutes on average to complete the entire survey (SD = 8.6 minutes).

Results and discussion

Participant vaccination data

The average level of support for vaccines, in general, was relatively high among our participants (M = 5.93, SD = 1.46 on our 7-point scale). Most participants reported they had received or planned to receive a COVID-19 vaccination (81.4%) and booster (64.8%). The vaccination rate is in line with the overall U.S. rate of vaccination rate of 78% as of June 29, 2022 (the day after data collection was completed. See https://usafacts.org/visualizations/covid-vaccine-tracker-states). Only 32% of Americans had received a booster as of June 29, 2022, suggesting our sample was more likely to be boosted than the general public. However, our question about booster status also left open the possibility that a participant was planning to receive a booster shot in the future, indicating this gap is likely smaller than it appears. Overall, these data suggest our sample was slightly more accepting of COVID-19 vaccines than the general public.

Explicit ratings of the health messages

All analyses were carried out using jamovi open-source statistics software. We conducted a series of one-way ANOVAs to compare the effect of each of the three stimulus vignettes for each of our five questions on ratings of understandability, informativeness, and persuasiveness. These analyses revealed that participants generally rated the metaphorical and literal responses for each question as similarly understandable, informative, and persuasive. There were, however, several notable significant differences, as revealed by Tukey’s post-hoc t-tests: For Question 1, the bank (M = 5.86, SD = 0.95) and castle (M = 5.89, SD = 1.42) metaphors were rated as more understandable than the literal message (M = 5.35, SD = 1.19); t(298) = 2.96, p = 0.009 and t(298) = 3.18, p = 0.005, respectively. For Question 4, the war metaphor was rated as both less understandable (M = 5.53, SD = 1.27 vs. M = 5.99, SD = 1.13; t(298) = 2.66, p = 0.023) and less informative (M = 5.00, SD = 1.56 vs. M = 5.54, SD = 1.27; and t(298) = 2.63, p = 0.025) than the speed limit metaphor. The war metaphor was also rated as less understandable than the literal message (M = 6.07, SD = 1.25; t(298) = 3.13, p = 0.005). Finally, for Question 5, the raincoat metaphor was rated as more persuasive than the literal message (M = 5.24, SD = 1.69 vs. M = 4.35, SD = 1.93; t(298) = 3.60, p = 0.001). See Table 4.

Table 4. Explicit ratings of each metaphor.

Question Stimulus Mean Rating (SD)
Understandable Informative Persuasive
1. How do vaccines work? Castle 5.89 (1.42) 5.82 (1.44) 5.29 (1.60)
Bank 5.86 (0.95) 5.71 (1.19) 5.35 (1.29)
Literal 5.35aa (1.19) 5.98 (1.07) 5.17 (1.39)
2: Is “natural immunity” better than the immunity provided by a vaccine? Pilot 5.80 (1.21) 5.54 (1.46) 5.16 (1.62)
Fire Drill 5.96 (1.04) 5.50 (1.35) 5.22 (1.50)
Literal 6.04 (1.32) 5.36 (1.33) 5.26 (1.62)
3: Are vaccines that are developed quickly safe? Cake 5.97 (1.12) 5.78 (1.23) 5.42 (1.44)
Video Game 5.94 (1.14) 5.58 (1.44) 5.13 (1.66)
Literal 5.88 (1.16) 5.46 (1.36) 5.09 (1.60)
4: Why should I take a vaccine if I am personally low-risk for the illness? Speed Limit 5.99 (1.13) 5.54b (1.27) 5.17 (1.73)
War 5.53aa (1.27) 5.00b (1.56) 4.78 (1.82)
Literal 6.07 (1.25) 5.43 (1.46) 5.00 (1.85)
5: Why get a vaccine if it isn’t 100% effective? Raincoat 5.86 (1.16) 5.60 (1.41) 5.24b (1.69)
Seatbelt 5.88 (1.23) 5.38 (1.39) 4.90 (1.61)
Literal 5.69 (1.14) 5.18 (1.49) 4.35b (1.93)

aa indicates this value significantly differs from the other two values within a cell, p < .05

b indicates these two values within a cell significantly differ, p < .05

This analysis suggests that certain metaphors may help or hinder communications about a particular topic. For example, using a bank or castle metaphor to explain how vaccines work may make a message easier to understand, though it does not appear to impact how informative or persuasive the message seems in relation to a comparable literal message. Using a war metaphor involving mobilization by a country under attack to explain why people should take a vaccine even if they are personally at low risk for the illness appears to be particularly ineffective, eliciting lower understandability and informativeness ratings. We offer additional evidence for the efficacy of certain metaphors in the linguistic analysis section below. Overall, however, the explicit ratings data indicate that people’s evaluations of the messages were only slightly impacted by the presence of a metaphor. For most of the comparisons, participants tended to perceive the metaphor-enriched messages as similarly understandable, persuasive, and informative as the messages that did not include an extended explanatory metaphor.

(How) Did overall vaccine attitudes change from pre- to posttest by condition?

We used a repeated-measures ANOVA comparing attitudes towards vaccines before and after participants read and rated the messages (VAM-pretest vs. VAM-posttest). Whether the participant received explanatory metaphor messages or literal messages was included as a between-subject factor (note that this analysis does not distinguish between which of the two metaphorical messages a participant received if they were in the metaphor condition). Previous research—including our own pilot testing—has shown that a variety of individual differences and demographics are associated with attitudes towards vaccines. Therefore, we analyzed age, self-reported science background, generic conspiracist beliefs, trust in institutions, and political ideology as covariates in the model. Two individuals left certain demographic variables blank and were therefore excluded from this analysis.

Overall vaccine attitudes became significantly more favorable from pretest (M = 4.98, SD = 1.22) to posttest (M = 5.23, SD = 1.24), F(1, 292) = 19.27, p < 0.001. However, there was no interaction between vaccine attitudes (pre- vs. posttest) and condition, F(1, 292) = 0.059, p = 0.81, as illustrated in Fig 1. These findings suggest that simply taking part in a study reading healthcare communications led to more favorable/accurate attitudes towards vaccines, whether or not extended explanatory metaphors were included in the messaging.

Fig 1. Mean pretest and posttest Vaccine Attitude Measures by condition.

Fig 1

Error bars represent standard errors of the mean. Data for all 301 participants is shown.

Interestingly, a significant within-subject effect was found in the interaction between vaccine attitudes (pre- vs. posttest) and trust in institutions, F(1, 292) = 7.17, p = 0.008. A similar effect was found for generic conspiracy beliefs, though this effect was marginal, F(1, 294) = 5.05, p = 0.05. People whose questionnaire responses indicated they had lower trust in institutions or more generic conspiracy beliefs showed a greater increase in vaccine attitude scores from pre to posttest compared to people with higher trust in institutions or fewer conspiracy beliefs. However, this is likely a result of lower pretest baseline scores for these low-trust and high-conspiracy individuals.

Three covariates independently predicted vaccine attitudes collapsing across pre- and posttest: (a) generic conspiracist beliefs (F(1, 292) = 154.86, p < 0.001), (b) political ideology (F(1, 292) = 118.96, p < 0.001), and (c) trust in institutions (F(1, 292) = 12.75, p < 0.001). Endorsing conspiracy beliefs, conservative political ideology, and lower trust in institutions were all associated with less favorable vaccine attitudes (i.e., lower scores on our measure). This is consistent with previous research on vaccine hesitancy [59] and provides additional empirical support for those findings while highlighting the validity of our adapted vaccine attitude measure.

Exploratory analyses by vaccine attitude sub-category

We conducted an identical repeated-measures analysis for each of the eight VAM sub-category scales, including all of the same covariates as before. This enabled us to explore whether the messages led to differential impacts on participants’ attitudes toward certain vaccine attitude items since some of the sub-categories corresponded directly to the content of the messages (e.g., sub-category 2, on “natural immunity,” corresponds to vaccine Question 2 “Is ‘natural immunity’ better than the immunity provided by a vaccine?”).

Overall, most of the same general patterns were obtained for the sub-category scales as for the total VAM analysis, though the findings are noisier due to increased variance in the smaller sub-scales. However, these data do suggest that health messages may have been particularly effective at targeting the specific content included in the messages. VAM scores increased significantly from pre- to posttest for sub-category scales 2 (F(1, 292) = 16.95, p < 0.001), 3 (F(1, 292) = 22.18, p < 0.001), and 5 (F(1, 292) = 12.65, p < 0.001). The effect for subscale 4 was similar, though this test did not quite reach significance (F(1, 292) = 3.88, p = 0.05). Interestingly, VAM scores decreased between pre- and posttest for sub-category scale 1, though not significantly (F(1, 292) = 3.33, p = 0.069), which is a finding we unpack in the General Discussion. Each of these sub-scales was associated with one of our target questions (see Tables 2 and 3). VAM scores did not significantly differ between pre- and posttest for sub-category scales 6, 7, and 8, though the numeric trends were in line with the increase observed in the other sub-scales. Sub-scales 6–8 tapped beliefs and attitudes that were not explicitly addressed in our health messages (i.e., personal attitudes towards vaccines, attitudes towards childhood vaccinations, and vaccine conspiracy beliefs). Future work is needed to develop messages to target these issues directly.

Whether or not the message included an explanatory metaphor was not a significant factor for any of the subscales, with one notable exception: For sub-category scale 2 (‘natural immunity’), scores increased significantly more between pre- and posttest for participants in the metaphor condition than the literal condition, F(1, 292) = 16.95, p = 0.036. See Fig 2. In exploratory research like the current study, the possibility of false positives must always be considered. However, this result may also indicate that metaphors are especially effective for communicating about this particular issue of natural immunity. Current research underway in our labs is further testing this intriguing possibility.

Fig 2. Mean pretest and posttest VAM subcategory 2 scale scores by condition.

Fig 2

Error bars represent standard errors of the mean. Data for all 301 participants is shown.

Linguistic analyses

As noted above, the current study aimed to advance traditional procedures in metaphor research in that we asked our participants to report how they would respond to a friend asking the target questions (“How would you respond to a friend who asked you…?”). Participants filled in a free-text response box, into which they could type without a time or character limit. This elicitation method, while not uncommon in social science and survey-based research (e.g., [54]), has not been used in prior metaphor framing research (although [22] used a related but more abstract ‘imagine a situation’ measure). This technique was designed to obtain data to triangulate the attitude measures of the efficacy of public health messaging. It also allowed us to gauge the extent to which the different explanatory metaphors participants read may have been memorable or ‘sticky’ for them (in the sense of engagement or involvement). We were interested to see whether metaphors participants had read were reused by them when they answered the vaccine-related concerns of their purported friend. The “explain to a friend” prompt also allowed us to investigate how the different explanatory metaphors were reused. Their free response data allowed us to touch upon social communication in interactions with friends and family in decisions about vaccinations. This dovetails with reports like the UK’s SAGE Working Group on Vaccine Hesitancy [9], where the authors include individual and group influences as one of three groups of determinants of vaccine hesitancy. As we took a first pass through the data, a preliminary posthoc analysis revealed that the answers to the “explain to a friend” prompt also provided novel participant-generated metaphors, which were not a focus of the current study. Although space constraints prevent a full discussion in the current paper, assessment of these data may reveal insightful information about the relationship between the original messages participants read and the new metaphors they constructed themselves to explain vaccines to their friends. We look forward to describing these findings in future reports.

Did the length of free-text responses (in terms of word tokens) differ depending on condition?

To address this component of participant responses, we calculated the length of free-text responses in terms of the number of words (tokens) used. The results are displayed in Table 5 and Fig 3.

Table 5. Cumulative and mean number of word tokens in free-text responses for each condition and question.
Condition # Tokens Question 1 Question 2 Question 3 Question 4 Question 5 Total
Literal
(N = 102)
Mean (SD) 25.3 (16.8) 22.5 (13.1) 24.9 (15.2) 23.6 (15.4) 22.8 (15.7) 119.2 (62.7)
Cumulative 2584 2291 2541 2412 2327
Metaphor
(N = 199)
Mean (SD) 26.8 (16.5) 28.7 (17.0) 29.4 (17.7) 27.6 (17.2) 27.9 (18.6) 140.5 (73.6)
Metaphor 1 Castle
(N = 101)
Pilot
(N = 101)
Cake
(N = 99)
Speed Limit
(N = 99)
Raincoat
(N = 100)
Mean (SD) 28.2 (18.0) 28.6 (16.3) 28.6 (17.5) 25.5 (15.7) 29.5 (18.4)
Cumulative 2848 2884 2836 2521 2954
Metaphor 2 Bank
(N = 98)
Fire Drill
(N = 98)
Video Game
(N = 100)
War
(N = 100)
Seatbelt
(N = 99)
Mean (SD) 25.4 (14.8) 28.9 (17.8) 30.2 (17.9) 29.8 (18.4) 26.3 (18.8)
Cumulative 2486 2835 3020 2981 2607
Fig 3. Percentage difference in mean word production on the “explain to a friend” free response task for each metaphor relative to the comparable literal condition.

Fig 3

Overall, participants in the metaphor condition (M = 140.5, SD = 73.6) used significantly more total words on average (~18%) in their “explain to a friend” responses than those in the literal condition (M = 119.2, SD = 62.7), t(299) = 2.51, p = 0.013, d = 0.31. This effect was observed fairly consistently across the questions. Participants used significantly more words in the metaphor condition than the literal condition for Question 2 (t(299) = 3.27, p = 0.001, d = 0.40), Question 3 (t(299) = 2.19, p = 0.029, d = 0.27), Question 4 t(299) = 1.98, p = 0.049, d = 0.24) and Question 5 (t(299) = 2.39, p = 0.018, d = 0.29), though not for Question 1 (t(299) = 0.73, p = 0.466, d = 0.09). See Table 5.

Breaking the word counts down by metaphor is illuminating. As illustrated in Table 5 and Fig 3, compared to participants who read literal passages, those who received the metaphorical messages used more words on average for all their explanations to a friend. This difference was negligible (0.4%) when comparing those who received the bank metaphor to those who read the literal passage for Question 1. Overall, however, the average word count for “explain to a friend” answers in eight out of the ten metaphor conditions was at least 10% higher than for the corresponding literal conditions. And in four of the metaphor conditions (pilot, fire drill, war, and raincoat), participants used more than 25% more words compared to those who received comparable literal messages.

To what extent were the metaphors participants read then reused in their explanations to a friend’s answers?

We also coded the “explain to a friend” responses in terms of whether or not the explanatory metaphor contained in the passage that each participant read was then reused by the participants in the explanations they said they would give to their friends. All data were double-coded by two research assistants who, after a 45-minute training session involving 5% of the data, proceeded with individual coding. Inter-rater reliability (IRR) was calculated using all data across the five metaphor stimuli using Cohen’s Kappa, revealing a high degree of agreement in binary Yes-No metaphor reuse (M Cohen’s Kappa = 0.94 across the five stimuli). The two coders met to resolve coding disagreements through additional discussion until they achieved complete agreement on all codes (M Cohen’s Kappa = 1.00 across the five stimuli). Table 6 and Fig 4 show the outcomes of the coding.

Table 6. Percentage of reuse of each explanatory metaphor in “explain to a friend” responses.
Reuses metaphor N reuses % reuses
Q1 Castle 22 21.78
Bank 23 23.47
Q2 Pilot 8 7.92
Fire Drill 8 8.16
Q3 Cake 9 9.09
Video Game 16 16.00
Q4 Speed Limit 9 9.09
War 7 7.00
Q5 Raincoat 27 27.00
Seatbelt 18 18.18
Fig 4. Percentage of reuse of each explanatory metaphor in “explain to a friend” responses.

Fig 4

Five of the metaphors were reused by more than 10% of the participants—raincoat, bank, castle, seatbelt, and video game—indicating that these metaphors were likely particularly salient for participants as they responded to the “explain to a friend” prompt. Three metaphors were reused to an even greater extent—by more than 20% of participants. These especially salient metaphors were castle (22%), bank (23%), and raincoat (27%).

The metaphors used in response to Questions 1 (“How do vaccines work?”) and 5 (“Why get a vaccine if it isn’t 100% effective?”) were reused most often. This might be because of the topic of the questions (e.g., how and why), or because of an inherent attribute of the metaphors (more memorable or”sticky”), or due to the interaction between the two. The two metaphors for Question 1 were reused to a similar extent, whereas the raincoat metaphor was reused more than the seatbelt metaphor in relation to Question 5. The metaphors for Question 2 were reused less often. When considering which specific metaphors were retained and reused by participants, we also found it interesting to look at how they were used.

How are the metaphors reused in free-text answers?

The first public health messaging question asked was “How do vaccines work?” The metaphors used in the explanatory passage were those of a castle (22 reuses) and a bank (23 reuses). For both metaphors, participant reusers can be divided between those who mention two lines of defense or security (13/22 for castle, 9/23 for bank) and those who only mention one (9/22 for castle, 14/23 for bank). This may be because the idea that vaccines help fight viruses and defend the body is conventional and popular in public health messaging, but the idea of two unique lines of defense may be less familiar to some people.

Examples of reuse with one line of defense can be seen in the following extracts from the data: “Vaccines work by training the body to recognize foreign invaders that can cause infections. The vaccine helps your body protect against them and fight them” and “Vaccines work like an alarm system to alert your body when a virus is trying to get in and to stop it.” Examples of reuse with two lines of defense can be seen in the following two extracts from the data: “Vaccines work like a medieval castle where you have multiple lines of defense including archers to protect the virus from getting in the castle and elite troops that help drive the virus out if it penetrates the castle walls (your body)” and “Getting a vaccine is like getting a comprehensive security system for your body, with two layers of defense. First, it has preventative measures, like security cameras, always on the lookout. But if one of the cameras fails and someone unwanted gets through, a team of trained security guards deals with them. This is how a vaccine might deal with a virus getting through.”

Interestingly, a few participants reused the metaphors in the explanatory passage while not getting the details of how vaccines work right, for example: “Your body has cells that fight like warriors. A virus tries to enter your body and if so these warriors (cells) try to fight it off, it if it can’t that is when the vaccine will also help as a back up.”

None of the castle reuses mention boosters, but three bank reuses do. We speculate that one possible reason for this may be because the idea of an”update" is more consistent with security systems than weapons: “They work like high tech security cameras that are watching and protecting you from intruders and can catch them before they make a severe impact and the boosters are like an upgrade to new features, or information that can help protect even more from getting in.”

In relation to Question 3, the video game metaphor was reused 16 times, which included several instances of resistance to the metaphor, for example, using the metaphorical scenario in a way that undermines the role of vaccines, as in the following extract from the data: “Safe compared to what? If you mean are rapidly developed vaccines tested enough to be proven safe then the answer is no. Editing vaccines isn’t like adding powers to a video game character. The effects of each new addition have to be thoroughly tested over time. If the disease is so severe that it threatens society, then cutting time to try and save lives may be warranted. Otherwise, vaccines shouldn’t be rushed or announced save without proper research to back up those claims” and “The article says yes and it’s just like a video game patch. However, we have seen that certain vaccines have worse side effects than others.” and finally, “No, they are not, because they have not been adequately tested. Just think of a video game, where the developer rolls out a new feature, sure that it will work as they planned. But, soon enough, the new feature begins acting buggy, and causing the whole game to lag and no longer work as it should. Then, the developer has to panic, and work around the clock to try and find a solution to the problem they inserted, all while trying to save their user base.”

Question 5 asks, “Why get a vaccine if it isn’t 100% effective?” The raincoat metaphor attracted 27 reuses, with participants using different aspects of the scenario, corresponding to different causes of increased risk of infection, for example, deficient raincoats vs. very bad weather. The following extracts from the data illustrate this range of reuses: “It is better to get protected 50% than 0% percent. Just like you would still wear a raincoat if even if [sic] it wasn’t the best raincoat ever, you should get a vaccine because it may protect you enough to keep you out of the hospital. Also it will protect others.” and, “It provides a high degree of protection against you becoming seriously ill. Would you rather wear a raincoat or walk around unprotected during a thunderstorm?” In the latter example, the use of a rhetorical question and the contrast between wearing a raincoat and being “unprotected during a thunderstorm” arguably have stronger evaluative and emotional associations than the wording used in the original stimulus text.

For some of the metaphors, reuses built upon and went beyond the stimulus texts in terms of the level of detail or main focus in the answers to the friend scenario. These tended to be by high reusers, for example, in response to the fire drill metaphor used to illustrate the explanation given to Question 2: “It is not! Think of vaccine immunity like training in a fire drill. You’re in a controlled environment where you’re not at high risk if something goes wrong. If you were in a real fire situation, just like trying natural immunity, if you panic or do something wrong you could get seriously hurt, or worse. But with the safety of a fire drill where there is no actual fire, you can make mistakes. Similarly, with a vaccine, your body is being trained to deal with infection in a safe, controlled manner.” There was a similar pattern in response to the cake metaphor used in the explanatory passage for Question 3: “I would respond that I think we have to think about how quickly the virus can mutate and we have to think about how if we don’t have some ready now and start getting people vaccinated that it’ll mutate worse and worse. We should look at it like a cake, the vaccine is the batter that is already pre-made and you come in to get a personalized message if more and more people came in and the batter wasn’t ready, the cake makers would be behind and as new mutations come in, they wouldn’t be able to control it and it would cause chaos.” Finally, we saw the same pattern of using the metaphor as a jumping-off point and going beyond it when explaining to a friend in participants who read the explanatory passage with the video game metaphor given to illustrate the answer to Question 3: “Quickly developed vaccines are perfectly safe. They’re not made from scratch. Think of older vaccines as a video game, like Minecraft. The framework is already there, already made. When a new vaccine needs to be made, that framework can be drawn upon. It’s like making a mod or downloading the latest patch for Minecraft—they don’t have to build Minecraft in a rush every time. They just take what exists and improve upon it.”

General discussion

The COVID-19 pandemic has helped illuminate the risks posed to public health by vaccine hesitancy. The development of effective messaging to improve vaccine attitudes may help improve public health outcomes. Metaphors are a promising tool for communicating about complex issues and have previously been shown to bolster persuasion and explanation [17, 18]. Perhaps not surprisingly, scientists, doctors, and public health officials often use metaphors to explain how vaccines work and to address common questions, concerns, and misconceptions. However, the effectiveness of these metaphors has not been convincingly demonstrated empirically (though some researchers have begun to address this issue, e.g., [37]). In the current study, we investigated the impact of a range of explanatory metaphors on vaccine attitudes. We also included a new methodological tool in metaphor research with the goal of opening a window to view the role of social communication in assessing the impact of metaphors.

For participants in our study, communicating with extended explanatory metaphors did not make a vaccine health message any more or less effective than communicating via a comparable literal message overall. The few exceptions we did find, though, may be useful for researchers and public health communicators who need to make choices about particular metaphors in the future. For example, our quantitative findings suggest that invoking a war metaphor involving a national mobilization scenario might be particularly ineffective in explaining why low-risk individuals should be vaccinated. Given that there is a wide range of possible available metaphors, using a different one is a simple choice. In contrast, the castle metaphor, which involves a different war-related scenario, was found to be potentially useful in communicating how vaccines work. This highlights the importance of considering specific scenarios and their associated narratives and structural entailments in developing metaphorical frames. Broader domains like war encompass a range of different scenarios that may be more or less effective when used as metaphors to explain particular target domains.

Our exploratory analysis has also revealed that using pilot training or fire drill metaphors to explain why natural immunity is not inherently superior or different from vaccine-induced immunity may be particularly effective. Future work is needed to replicate these findings, but they speak to the potential promise of certain metaphorical messages over others in addressing common misconceptions about vaccines.

Regardless of whether participants read messages with or without metaphors, there was a small but significant increase in favorable attitudes towards vaccines after reading health care messages. This argues for the effectiveness of communications about vaccines and is a positive finding for healthcare messaging in general.

Exploratory analyses of our VAM subscales provided some evidence that vaccine attitudes were especially likely to improve for issues directly addressed by our health messages and may have been less likely to improve for issues we did not cover directly (e.g., vaccine conspiracies and childhood vaccinations; as illustrated in the data presented in Tables 2 and 3). The only VAM subscale that was directly tied to one of our target questions/messages and that showed a decrease from pre- to posttest concerned how vaccines work (subscale 1). This suggests there may be issues with the specific items in this subscale. It is possible the two reverse-coded items were confusing. Vaccines are not technically “designed to target and neutralize viruses that enter the body,” nor do they “contain new antibodies designed to deal with infections.” But vaccines do essentially function to help the body create new antibodies to target and neutralize viruses, so participants may have interpreted the statements in that way. In future work, we plan to clarify the language in these statements to avoid confusion.

Our findings also replicate previous research showing that specific individual difference factors can be associated with more negative attitudes toward vaccines. These include political ideology and trust in institutions. Importantly, though, controlling for these factors did not eliminate the impact of the health messages. This demonstrates that brief educational interventions on this subject can be effective, even for individuals who show evidence of vaccine-hesitant beliefs at the start. Again, this is a positive finding for the efficacy of healthcare messaging in general.

One innovative aspect of the present study was the inclusion of free-text responses where participants thought about and reported how they would answer each target question if posed by a friend (cf. [22]). Our linguistic analyses revealed people who read messages containing metaphors produced about 18% more words on average in free-text responses than participants who received the corresponding literal messages. Metaphors, then, seem to provide additional vocabulary and imagery that can be exploited in social relationships—in this case, communicating with a friend. This is particularly relevant given the importance of social networks in decisions about vaccinations [9].

Notably, and somewhat unexpectedly, we found that most participants did not reuse the metaphors they had read. The higher word count produced in the metaphor condition suggests that exposure to metaphors results in participants being more productive, or fluent, in producing explanations. Thus, even though providing explanatory metaphors did not directly lead to the reuse of those metaphors, we still saw evidence of a critical metaphor framing effect. On the basis of these data, we posit that exposure to explanatory metaphors may help people organize their understanding of vaccines in a way that facilitates and enriches their subsequent (at least, immediately proximal) communications about the issue. Our study illustrates the potential of this methodology for obtaining insights that go beyond the common quantitively oriented survey techniques that have so far been the primary means of investigating the effects of metaphors on attitudes and decision-making.

Like social communication, individual variation in metaphor use has not received much attention in previous work either. Our linguistic analysis identified a small group who were very competent at reusing the metaphors they read. In addition to this, other participants generated their own explanatory metaphors that were not included in the health messages they received. Our ongoing research is investigating these issues further since we believe they warrant additional attention.

There are, of course, multiple limitations in a study such as ours. Our participants were limited to North American users of Amazon’s Mechanical Turk (MTurk). While this platform is widely used in social science research and has proven to be a reliable sampling resource [55, 56], some scholars have recently voiced concerns about the presence of bots and other data quality issues [57]. While we implemented several best practices designed to mitigate these problems (e.g., including an attention check question and using CloudResearch to recruit participants, which pre-screens MTurk users and has been shown to yield higher quality data [40, 41]), future work should aim to replicate these findings with alternative populations. Relatedly, the lack of geographic diversity means our results may be of limited generalizability. As we alluded to above, individual differences may change the way people understand or perceive the metaphors, with downstream consequences for their vaccine attitudes. Although we piloted every aspect of the design, the questions organizing our fictional messaging campaign may not be formulated in a way that resonates with many outside “WEIRD” populations [58]. Future work should extend these methods to other languages and cultures. Additionally, we did not consider the full set of possible metaphors or uses of metaphor in the context of vaccine communication, which limits the generalizability of our findings. Other research has found that using emotionally charged metaphors for a virus (e.g., beast, riot, army)—rather than for vaccines—may increase the willingness to get vaccinated, though more research is needed on this topic [36].

While our adapted Vaccine Attitudes Measure showed evidence of reliability and validity, we have documented possible issues with certain statements that may have confused participants. We are refining the measure for use in future work. Similarly, our linguistic analysis—while having very high inter-rater reliability—comprises a novel use of a borrowed methodology in metaphor research, and its use should, therefore, be viewed as exploratory in nature in this initial study. Additionally, the fact that we did not find clear effects for metaphors over comparable literal passages on vaccine attitudes may not be because there are none but because of the topic of vaccinations itself—which, at the point of data collection, was something many participants would have strong views about due to the timing of this study in the COVID pandemic. Our ongoing work is investigating these research questions with different topics and in both the U.K. and the U.S. contexts. Future work could also usefully consider differences in responses to metaphors depending on whether they emphasize the benefits of vaccination for the individual (e.g., castle, bank, raincoat, and seatbelt metaphors) vs. benefit for others (e.g., speed limits and war metaphors). For example, a randomized control trial on the effects on U.K. adults of different types of vaccine information strategies during the COVID-19 pandemic found that, for strongly vaccine-hesitant participants, information about the personal benefit of vaccination reduces hesitancy to a greater extent than information about collective benefits [59].

Notwithstanding these limitations, we have shown that (1) Brief health messaging passages have the potential to improve attitudes towards vaccines, (2) Explanatory metaphors neither enhance nor reduce this effect relative to comparable literal passages, but (3) Explanatory metaphors may be more helpful than comparable”literal” language in facilitating further social communication about vaccines. Fully addressing vaccine education and hesitancy will take more than a simple 10-minute online intervention. However, we believe our study represents one cost-effective method for systematically generating and testing messages that healthcare workers and everyday citizens might use in interpersonal, on-the-ground communications. We hope that these findings will both aid and inspire future research on the functions of metaphor in explanation in general and vaccine hesitancy in particular.

Acknowledgments

We would like to thank K. Cook, E. Fell, and D. Reagan for their assistance with coding the linguistic data and formatting the paper and E. Fell for her invaluable work preparing the revised and final versions.

Data Availability

Data are publicly available on the Open Science Framework at the following link: https://osf.io/jg9st/.

Funding Statement

This work was funded by UK Research and Innovation, grant numbers: ES/R008906/1 and ES/V000926/1 to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organization; Newsroom. Ten threats to global health in 2019 [Internet]. World Health Organization. 2019. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019. [Google Scholar]
  • 2.Goldenberg MJ. Vaccine hesitancy: public trust, expertise, and the war on science. University of Pittsburgh Press; 2021. [Google Scholar]
  • 3.Poltorak M, Leach M, Fairhead J, Cassell J. ‘MMR talk’ and vaccination choices: An ethnographic study in Brighton. Social Science & Medicine. 2005. Aug 1;61(3):709–19. doi: 10.1016/j.socscimed.2004.12.014 [DOI] [PubMed] [Google Scholar]
  • 4.Kitta A, Goldberg DS. The significance of folklore for vaccine policy: discarding the deficit model. Critical Public Health. 2017. Aug 8;27(4):506–14. [Google Scholar]
  • 5.Hudson A, Montelpare WJ. Predictors of vaccine hesitancy: Implications for COVID-19 public health messaging. Int J Environ Res Public Health [Internet]. 2021;18(15):8054. Available from: doi: 10.3390/ijerph18158054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur [Internet]. 2021;1(100012):100012. Available from: doi: 10.1016/j.lanepe.2020.100012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rathje S, He JK, Roozenbeek J, Van Bavel JJ, van der Linden S. Social media behavior is associated with vaccine hesitancy. PNAS Nexus [Internet]. 2022;1(4):gac207. Available from: doi: 10.1093/pnasnexus/pgac207 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: a critical review. Soc Sci Med [Internet]. 2014;112:1–11. Available from: doi: 10.1016/j.socscimed.2014.04.018 [DOI] [PubMed] [Google Scholar]
  • 9.SAGE Working Group on Vaccine Hesitancy. Report of the SAGE Working Group on Vaccine Hesitancy [Internet]. 2014. Available from: https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf.
  • 10.Lawrence HY. Vaccine rhetorics. The Ohio State University Press; 2020. [Google Scholar]
  • 11.Lakoff G, Johnson M. Metaphors we live by. Chicago, IL: University of Chicago Press; 2003. [Google Scholar]
  • 12.Musolff A. Metaphor scenarios in public discourse. Metaphor and Symbol. 2006;21(1): 23–38. Available from: 10.1207/s15327868ms2101_2. [DOI] [Google Scholar]
  • 13.Musolff A. Political and metaphor analysis: Discourse and scenarios. London: Bloomsbury, 2016. [Google Scholar]
  • 14.Semino E, Demjén Z, Demmen J. An integrated approach to metaphor and framing in cognition, discourse, and practice, with an application to metaphors for cancer. Applied linguistics. 2018. Oct 1;39(5):625–45. [Google Scholar]
  • 15.Gibbs RW Jr. Metaphor wars: Conceptual metaphors in human life. Cambridge, England: Cambridge University Press; 2019. [Google Scholar]
  • 16.Holyoak KJ, Stamenković D. Metaphor comprehension: A critical review of theories and evidence. Psychol Bull [Internet]. 2018;144(6):641–71. Available from: doi: 10.1037/bul0000145 [DOI] [PubMed] [Google Scholar]
  • 17.Thibodeau PH, Hendricks RK, Boroditsky L. How linguistic metaphor scaffolds reasoning. Trends Cogn Sci [Internet]. 2017;21(11):852–63. Available from: doi: 10.1016/j.tics.2017.07.001 [DOI] [PubMed] [Google Scholar]
  • 18.Thibodeau PH, Matlock T, Flusberg SJ. The role of metaphor in communication and thought. Lang Linguist Compass [Internet]. 2019;13(5):e12327. Available from: 10.1111/lnc3.12327. [DOI] [Google Scholar]
  • 19.Flusberg SJ, Matlock T, Thibodeau PH. Metaphors for the war (or race) against climate change. Environ Commun [Internet]. 2017;11(6):769–83. Available from: 10.1080/17524032.2017.1289111. [DOI] [Google Scholar]
  • 20.Thibodeau PH, Boroditsky L. Metaphors we think with: the role of metaphor in reasoning. PLoS One [Internet]. 2011;6(2):e16782. Available from: doi: 10.1371/journal.pone.0016782 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hauser DJ, Schwarz N. The war on prevention: bellicose cancer metaphors hurt (some) prevention intentions: Bellicose cancer metaphors hurt (some) prevention intentions. Pers Soc Psychol Bull [Internet]. 2015;41(1):66–77. Available from: 10.1177/0146167214557006. [DOI] [PubMed] [Google Scholar]
  • 22.Hendricks RK, Demjén Z, Semino E, Boroditsky L. Emotional implications of metaphor: Consequences of metaphor framing for mindset about cancer. Metaphor Symb [Internet]. 2018;33(4):267–79. Available from: 10.1080/10926488.2018.1549835. [DOI] [Google Scholar]
  • 23.Thibodeau PH, Flusberg SJ. Metaphorical accounting: How framing the federal budget like a household’s affects voting intentions. Cogn Sci [Internet]. 2017;41:1168–82. Available from: doi: 10.1111/cogs.12475 [DOI] [PubMed] [Google Scholar]
  • 24.Panzeri F, Di Paola S, Domaneschi F. Does the COVID-19 war metaphor influence reasoning? PLoS One [Internet]. 2021;16(4):e0250651. Available from: doi: 10.1371/journal.pone.0250651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Flusberg SJ, Lauria M, Balko S, Thibodeau PH. Effects of communication modality and speaker identity on metaphor framing. Metaphor Symb [Internet]. 2020;35(2):136–52. Available from: 10.1080/10926488.2020.1767336. [DOI] [Google Scholar]
  • 26.Landau MJ, Keefer LA, Swanson TJ. “undoing” a rhetorical metaphor: Testing the metaphor extension strategy. Metaphor Symb [Internet]. 2017;32(2):63–83. Available from: 10.1080/10926488.2017.1297619. [DOI] [Google Scholar]
  • 27.Thibodeau PH. Extended metaphors are the home runs of persuasion: Don’t fumble the phrase. Metaphor Symb [Internet]. 2016;31(2):53–72. Available from: 10.1080/10926488.2016.1150756. [DOI] [Google Scholar]
  • 28.Ahrens K., Burgers C., Zhong Y. Evaluating the influence of metaphor in news on foreign-policy support. International Journal of Communication. 2022;16:4140–63. [Google Scholar]
  • 29.Littlemore J, Sobrino PP, Houghton D, Shi J, Winter B. What makes a good metaphor? A cross-cultural study of computer-generated metaphor appreciation. Metaphor Symb [Internet]. 2018;33(2):101–22. Available from: 10.1080/10926488.2018.1434944. [DOI] [Google Scholar]
  • 30.Brugman BC, Droog E, Reijnierse WG, Leymann S, Frezza G, Renardel de Lavalette KY. Audience perceptions of COVID-19 metaphors: The role of source domain and country context. Metaphor Symb [Internet]. 2022;37(2):101–13. Available from: 10.1080/10926488.2021.1948332 [DOI] [Google Scholar]
  • 31.Landau MJ, Arndt J, Cameron LD. Do metaphors in health messages work? Exploring emotional and cognitive factors. J Exp Soc Psychol [Internet]. 2018;74:135–49. Available from: doi: 10.1016/j.jesp.2017.09.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Thibodeau PH, Boroditsky L. Natural language metaphors covertly influence reasoning. PLoS One [Internet]. 2013;8(1):e52961. Available from: doi: 10.1371/journal.pone.0052961 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.How is the COVID-19 vaccine like a seatbelt? [Internet]. Northeast Georgia Health System. 2021. Available from: https://www.nghs.com/2021/02/10/how-is-the-covid-19-vaccine-like-a-seat-belt.
  • 34.[@sailorrooscout]. Concerning breakthrough infections. Think of the vaccine as a very effective raincoat. If it’s drizzling, you’ll be protected. If the rain is coming down hard, you might still be fine. But if you are going in and out of rainstorms all the time, you could end up getting wet [Internet]. Twitter. 2021, July 13. Available from: https://twitter.com/sailorrooscout/status/1414913768803422213?s=20.
  • 35.Gilbert S, Green C, & Crewe D. VAXXERS: the inside story of the Oxford AstraZeneca vaccine and the race against the virus. 2021; Hodder & Stoughton [Google Scholar]
  • 36.Scherer AM, Scherer LD, Fagerlin A. Getting ahead of illness: using metaphors to influence medical decision making: Using metaphors to influence medical decision making. Med Decis Making [Internet]. 2015;35(1):37–45. Available from: 10.1177/0272989X14522547. [DOI] [PubMed] [Google Scholar]
  • 37.Ervas F., Salis P., Sechi C., & Fanari R. Exploring metaphor’s communicative effects in reasoning on vaccination. Frontiers in Psychology. 2022;13, 1027733. doi: 10.3389/fpsyg.2022.1027733 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Buhrmester M., Kwang T., & Gosling S. D. Amazon’s mechanical turk. Perspectives on Psychological Science. 2011;6(1):3–5. [DOI] [PubMed] [Google Scholar]
  • 39.Litman L, Robinson J, Abberbock T. Turkprime.com: A versatile crowdsourcing data acquisition platform for the behavioral sciences. Behav Res Methods [Internet]. 2017;49(2):433–42. Available from: doi: 10.3758/s13428-016-0727-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Douglas BD, Ewell PJ, Brauer M. Data quality in online human-subjects research: Comparisons between MTurk, Prolific, CloudResearch, Qualtrics, and SONA. PLoS One [Internet]. 2023;18(3):e0279720. Available from: doi: 10.1371/journal.pone.0279720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rivera ED, Wilkowski BM, Moss AJ, Rosenzweig C, Litman L. Assessing the Efficacy of a Participant-Vetting Procedure to Improve Data-Quality on Amazon’s Mechanical Turk. Methodology. 2022. Jun 30;18(2):126–43. [Google Scholar]
  • 42.Elmore KC, Luna-Lucero M. Light bulbs or seeds? How metaphors for ideas influence judgments about genius. Soc Psychol Personal Sci [Internet]. 2017;8(2):200–8. Available from: 10.1177/1948550616667611 [DOI] [Google Scholar]
  • 43.Landau MJ, Cameron LD, Arndt J, Hamilton WK, Swanson TJ, Bultmann M. Beneath the surface: Abstract construal mindset increases receptivity to metaphors in health communications. Soc Cogn [Internet]. 2019;37(3):314–40. Available from: doi: 10.1521/soco.2019.37.3.314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Martin LR, Petrie KJ. Understanding the dimensions of anti-vaccination attitudes: The vaccination attitudes examination (VAX) scale. Ann Behav Med [Internet]. 2017;51(5):652–60. Available from: doi: 10.1007/s12160-017-9888-y [DOI] [PubMed] [Google Scholar]
  • 45.Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, et al. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine [Internet]. 2018;36(5):660–7. Available from: doi: 10.1016/j.vaccine.2017.12.043 [DOI] [PubMed] [Google Scholar]
  • 46.Shapiro GK, Holding A, Perez S, Amsel R, Rosberger Z. Validation of the vaccine conspiracy beliefs scale. Papillomavirus Res [Internet]. 2016;2:167–72. Available from: doi: 10.1016/j.pvr.2016.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.CDC. Myths and facts about COVID-19 vaccines [Internet]. Centers for Disease Control and Prevention. 2023. [cited 2023 Mar 28]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/facts.html. [Google Scholar]
  • 48.Vaccine myths [Internet]. Immunology.org. [cited 2023 Mar 28]. Available from: https://www.immunology.org/public-information/vaccine-resources/vaccines/guide-childhood-vaccinations/vaccine-myths.
  • 49.Vaccines and immunization: Myths and misconceptions [Internet]. Who.int. [cited 2023 Mar 28]. Available from: https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-myths-and-misconceptions.
  • 50.Flesch R. A new readability yardstick. Journal of applied psychology. 1948. Jun;32(3):221. doi: 10.1037/h0057532 [DOI] [PubMed] [Google Scholar]
  • 51.Brotherton R., French C. C., Pickering A. D. Measuring belief in conspiracy theories: The generic conspiracist beliefs scale. Frontiers in Psychology. 2013;4:279. doi: 10.3389/fpsyg.2013.00279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.OECD. OECD Guidelines on Measuring Trust. OECD; 2017. [Google Scholar]
  • 53.Thibodeau P, Winneg A, Frantz C, Flusberg S. The mind is an ecosystem: Systemic metaphors promote systems thinking. Metaphor Soc World [Internet]. 2016;6(2):225–42. Available from: 10.1075/msw.6.2.03thi. [DOI] [Google Scholar]
  • 54.Mackey A, Gass SM. Second language research: Methodology and design. New York: Routledge; 2021. [Google Scholar]
  • 55.Clifford S, Jewell RM, Waggoner PD. Are samples drawn from Mechanical Turk valid for research on political ideology? Research & Politics. 2015. Dec 14;2(4):2053168015622072. [Google Scholar]
  • 56.Mullinix KJ, Leeper TJ, Druckman JN, Freese J. The generalizability of survey experiments. Journal of Experimental Political Science. 2015;2(2):109–38. [Google Scholar]
  • 57.Webb MA, Tangney JP. Too good to be true: Bots and bad data from Mechanical Turk. Perspectives on Psychological Science. 2022. Nov 7:17456916221120027. doi: 10.1177/17456916221120027 [DOI] [PubMed] [Google Scholar]
  • 58.Henrich J, Heine SJ, Norenzayan A. The weirdest people in the world? Behav Brain Sci [Internet]. 2010;33(2–3):61–83; discussion 83–135. Available from: doi: 10.1017/S0140525X0999152X [DOI] [PubMed] [Google Scholar]
  • 59.Freeman D, Loe BS, Yu LM, Freeman J, Chadwick A, Vaccari C, et al. Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): A single-blind, parallel-group, randomised controlled trial. The Lancet Public Health. 2021. Jun 1;6(6):e416–27. doi: 10.1016/S2468-2667(21)00096-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Wojciech Trzebiński

14 Jun 2023

PONE-D-23-09747Seatbelts and Raincoats, or Banks and Castles: Investigating the Impact of Vaccine MetaphorsPLOS ONE

Dear Dr. Flusberg,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Specifically, the Reviewers pointed out sever issues demanding more details in the manuscript (including method description and reporting results). On top of that, please move details related to your study design from section 1.3 ("The current study")  to the section 2 ("Method"). Instead, it would be valuable to elaborate on your research question and the corresponding research gap in section 1.3.

Please submit your revised manuscript by Jul 29 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wojciech Trzebinski, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

This work was funded by UK Research and Innovation, grant numbers: ES/R008906/1 and ES/V000926/1 to ES

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript is a well-written research study assessing vaccine attitudes of study participants following review and rating of metaphorical and literal responses to 5 common vaccine questions. There are some concerns regarding interpretation of the study findings that should be addressed prior to publication of this manuscript.

Major concerns:

1) Regarding section ‘3.2. Explicit ratings of the health messages (page 19 starting at line 333)’

a. Only significant differences are reported of participant ratings of how understandable, informative, or persuasive the metaphor or literal response is. A table summarizing all ratings data (understandable, informative, persuasive) and p-values for each of the 5 questions is much needed in order to be able to interpret the study findings.

b. Within this section, a broad conclusion is made that metaphorical messages are similar to literal messages, even though there is data indicating significant differences between metaphor and literal ratings. Page 19, line 339-343: The authors state, “These results indicate that people’s explicit judgments about the efficacy of the messages were roughly equivalent for all the messages targeting a given question, with a few minor exceptions. In other words, participants tended to perceive metaphor-framed messages as similar in terms of effectiveness when compared to comparable literal descriptions that do not include an extended explanatory metaphor.” It is not appropriate to refer to the significant differences found for question 1 and 5 as “similar” with “a few minor exceptions.” Given that the statistical differences are unique to each of the 5 questions that address different aspects of vaccine hesitancy, they should be interpreted separately, and these sentences should be revised.

c. The interpretation of the ratings of the 5 questions is presented as a conclusion in the abstract. Last sentence of abstract and page 35, line 677: “(2) Metaphors neither enhance nor reduce this effect relative to comparable literal passages.” Given the significant differences in ratings between the metaphor and literal messages, this conclusion is incorrect and warrants revision in line with the suggested revisions to section 3.2.

2) In this study, the authors investigated the impact of explanatory metaphors on vaccine attitudes assessed by a Vaccine Attitude Measures tool. A general conclusion was made that “metaphors are comparable to literal passages.” Their conclusion is contradictory to other studies that have shown positive correlations between patient receipt of a vaccine following a conversation with a physician who used a metaphor. This difference in study outcomes was never addressed in the publication and warrants a brief discussion.

Reviewer #2: I enjoyed this article and learned a lot from the authors’ careful study design and relevant findings. I think that this study would be of great interest to PLOS ONE readers, and I hope to see it published. The study was well designed, and I was especially interested in the original part of the study design that asked participants to “explain it to a friend” and answer vaccine-related questions in their own words. The findings are useful in contributing to a better understanding of how audiences and readers engage different types of vaccine-related information and how information and beliefs and decisions influence one another or not.

As I wrote above, I was most interested in the findings related to the authors’ method of asking participants to then answer a similar question as if it were posed by a friend. This participatory design -esque angle to vaccine and other forms of public health communication is original and exciting. I was very interested to learn about if and how participants used the metaphors that had just been modeled for them, and I wanted to read more about the ways that participants, when asked to take the reigns and answer this question for a hypothetical friend, improvised their own forms of vaccine communication. Thinking about Covid vaccination learnings, we learned that one of the biggest indicators that someone would be vaccinated against Covid was how many people they knew who were vaccinated. This correlation suggests that people are influenced a lot by those around them and suggests that lay vaccine communicators might have a lot to teach us about vaccination communication! I would look forward to reading an article about these findings and their implications.

I did have a few smaller suggestions that I think would help the article (1) better engage with vaccine-related scholarship and (2) clear up a few confusions I had about the study’s methods.

LITERATURE REVIEW

This comment isn’t one that I think absolutely needs to be addressed, but I did want to note that I wished the authors had addressed the growing body of work that investigates why people believe the things they believe about vaccines - i.e., the people the research team is trying and persuade with these metaphors.

I was wary that the authors avoided any reference to scholarship in the social sciences and humanities that has examined how people come to their vaccine beliefs and has largely concluded that deficit-based messaging approaches to vaccine communication and persuasion don’t work very well. Research shows us that, in short, the assumption that people are vaccine hesitant because of ignorance or misinformation and that their beliefs can be “corrected” by delivering persuasive and accurate information is limited. Instead, vaccine beliefs are complicated, fluid, and inextricable from their specific, social situations and histories. Changing vaccine hesitancy involves building trusted, long-term relationships with individuals and communities, not necessarily trying to package the right message and find the right messenger. Here I’m thinking of work by Bernice Hausman, Elena Conis, Nicole Charles, JEnnifer Reich, Maya Goldenberg, Heidi Lawrence, Melissa Leach & James Fairhead, Clare Decoteau, and Andrea Kitta.

I’ll add that this broader more contextualized approach to vaccine hesitancy as a complex social problem rather than a problem of individuals who believe the wrong things came, briefly, into mainstream vaccine discourse during the phased distribution of Covid vaccines, a time when there was a lot of talk about how and why, for example, people without health insurance might be vaccine hesitant because they don’t trust the systems that produce vaccines to look out for them (and not because they don’t understand or trust the vaccine, specifically), or why Americans of color would be skeptical of the US healthcare system and hold off on signing up for a new vaccine.

This isn’t to say that studies focused on questions about effective messaging don’t have a place – as I’ve written in the rest of the review, I think there’s so much of value in this study – but especially in a study that is attuned to audience and learning how targeted audience members make sense of and are or are not changed by a message, I would love to see, in the literature review sections, acknowledgement of the humanistic and social science work out there that is investigating and producing really important findings about how people come to their health beliefs and decisions.

METHODS

Recruitment

I wanted to know more about the limitations and reasons for using Amazon’s mTurk as a recruitment tool. Obviously it’s easy to recruit participants through this tool, but are there other, more research-driven reasons the authors chose to use mTurk?

In particular, I think the authors should discuss to what extent mTurk participants are a representative group to draw conclusions about general vaccination feelings, beliefs, and persuade-ability. I’m thinking again of all of the great social sciences and humanistic work that argues that real and effective vaccine communication must be built in relationships over time. That is, communicating scientific facts to people–even in culturally specific and artful ways–doesn’t work because this kind of generalized, mass communication rarely addresses people’s actual concerns, which are grounded in their lives, experiences, personal and collective histories, and social networks. So vaccine communication needs to be localized, iterative, and built into broader networks of relationships and trust. By asking mTurk anonymous participants who are likely churning through digital tasks one after another to share a bit about their responses to vaccine messages, the authors are not aligning themselves with this body of research. So I wondered what scholarship the authors are drawing on to endorse learning about vaccine beliefs and changes in belief in this way, that is, in a way that asks people to type a bit about their vaccine decisions made hypothetically, abstracted from all context, and only in hypothetical terms?

The research design – asking people to take assessments about conspiracy beliefs, vaccine beliefs, etc., and using an attention check to select participants more likely to actually read the prompts – all looked great. But I wanted to better understand how, in light of so much research pointing to vaccine decision-making as complex, situational, and tied to specific, local contexts, this method is useful to generate knowledge that *actually* captures how people are making vaccine decisions.

I also think the Methods section should address how participants were compensated.

Study design

I wondered about the authors’ choice to use similar metaphors to answer the question “How do vaccines work?” Based on existing scholarship on vaccines and metaphors, both of these metaphors would fall into a category of older commonplace metaphors about bodies, vaccines, and disease–metaphors that see each body as a sealed-off, fortress-like entity that defends itself against outside germs. By contrast, a more contemporary metaphor by which many people understand the body and immunity is that of a complex system (flexible immunity) – the body constantly adapts to its environment and grows stronger through encounters with pathogens and other things, like dirt. (Emily Martin’s work on immunity and immune systems metaphors is foundational here, but other scholarship on vaccination and metaphors has taken up and extended this argument. So, it seems like both of the metaphors here rely on the older model of the body - a discrete self that must be defended - rather than this flexible immunity model. I wonder if the authors can speak to this decision?

I wondered why the authors didn’t consider race as a demographic feature that influences vaccine decision making and trust in institutions (p. 20, lines 356 - 359)?

On p 15 lines 247-8, the authors write “After reading one of the three explanations associated with a particular question,participants were asked to consider how the general public would react to the message and to keep this in mind while responding to four questions.” I didn’t understand why the authors asked the participants to imagine how a general public audience would respond to the persuasive messaging. Isn’t the goal of the study to track how individual participants respond to the messaging? And to see how individuals respond to and are affected by the messages? It seems the participants should be reporting on their own impressions–how easy each participant found a passage to understand, how informative each participant found a passage–and not trying to speak for an imagined, general public audience.

Not a point that needs to be addressed, but a possibly generative question I had while reading:

I was interested in how the results about which metaphors were effective and ineffective might reveal more about public understandings of public health more so than the effectiveness of individual metaphors. For example, the metaphors that rely on individualist ideas of health (i.e., do things that maximize your own personal health and minimize risks to your own persona health) were the more clear, salient, and effective metaphors (e.g., Bank metaphor, Castle metaphor, Raincoat metaphor) And the metaphors that asked audiences to think about health as an interdependent, community state, one in which we should make decisions toward a greater social good fell flat (the war metaphor). Do these findings suggest that specific metaphors themselves were more or less clear or do they suggest that metaphors, arguments, policies, etc that align with individualist notions of health make more sense than metaphors, arguments, polities, etc that align with collective approaches to health?

Sentence-level points

Is there a reason to use the word “Interestingly” on p 3 line 53? And “presciently”? (Global vaccine hesitancy was already a big problem in 2019, so more accurate than prescient, I would say).

Typo on p 4 line 87

I had trouble following the last 2 analytical sentences of the section “1.2. Explanatory metaphors in vaccine discourse” (on p. 8, lines 150 -6)

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Kari Campeau

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 3;19(1):e0294739. doi: 10.1371/journal.pone.0294739.r002

Author response to Decision Letter 0


24 Jul 2023

PONE-D-23-09747

Seatbelts and Raincoats, or Banks and Castles: Investigating the Impact of Vaccine Metaphors

PLOS ONE

Dear Dr. Flusberg,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Specifically, the Reviewers pointed out several issues demanding more details in the manuscript (including method description and reporting results). On top of that, please move details related to your study design from section 1.3 ("The current study") to the section 2 ("Method"). Instead, it would be valuable to elaborate on your research question and the corresponding research gap in section 1.3.

****We have now moved this information as requested.

Please submit your revised manuscript by Jul 29 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

● A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

● A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

● An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wojciech Trzebinski, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf

and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

The title page has been corrected.

2. Thank you for stating the following financial disclosure:

This work was funded by UK Research and Innovation, grant numbers: ES/R008906/1 and ES/V000926/1 to ES

Please state what role the funders took in the study. If the funders had no role, please state:

"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

***We have added this information to our cover letter.

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

No changes necessary, we have shared all of our data to the Open Science Framework repository listed in the paper. If the paper is accepted for publication, we will de-anonymize the link in the final version.

4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

*****We have added the following statement to the Participants section:

“All participants gave informed consent prior to beginning the study. This study was reviewed and approved under reference FASSLUMS-2021-0576-RECR-2 by the Faculty of Arts and Social Sciences - Lancaster University Management School Research Ethics Committee at Lancaster University, U.K. (FASS-LUMS).”

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript is a well-written research study assessing vaccine attitudes of study participants following review and rating of metaphorical and literal responses to 5 common vaccine questions. There are some concerns regarding interpretation of the study findings that should be addressed prior to publication of this manuscript.

Major concerns:

1) Regarding section ‘3.2. Explicit ratings of the health messages (page 19 starting at line 333)’

a. Only significant differences are reported of participant ratings of how understandable, informative, or persuasive the metaphor or literal response is. A table summarizing all ratings data (understandable, informative, persuasive) and p-values for each of the 5 questions is much needed in order to be able to interpret the study findings.

***We appreciate this helpful suggestion and agree that a table summarizing the ratings data would be useful. We have now added the table (Table 4, pages 20-21).

b. Within this section, a broad conclusion is made that metaphorical messages are similar to literal messages, even though there is data indicating significant differences between metaphor and literal ratings. Page 19, line 339-343: The authors state, “These results indicate that people’s explicit judgments about the efficacy of the messages were roughly equivalent for all the messages targeting a given question, with a few minor exceptions. In other words, participants tended to perceive metaphor-framed messages as similar in terms of effectiveness when compared to comparable literal descriptions that do not include an extended explanatory metaphor.” It is not appropriate to refer to the significant differences found for question 1 and 5 as “similar” with “a few minor exceptions.” Given that the statistical differences are unique to each of the 5 questions that address different aspects of vaccine hesitancy, they should be interpreted separately, and these sentences should be revised.

***We also appreciate this point and apologize for the confusion. The reason we included the statement that the ratings across stimuli were “roughly” equivalent was because there were only six statistically significant differences out of 45 total post-hoc t-test comparisons (5 questions X 3 stimuli X 3 rating categories). However, following the reviewer’s comment, it is clear to us that this statement obscures over meaningful differences in the data. We have now edited this section of the manuscript for additional clarity, nuance, and accuracy (p. 21) to address the concern, as follows:

“This analysis suggests that certain metaphors may help or hinder communications about a particular topic. For example, using a Bank or Castle metaphor to explain how vaccines work may make a message easier to understand, though it does not appear to impact how informative or persuasive the message seems in relation to a comparable literal message. Using a War metaphor to explain why people should take a vaccine if they are personally at low risk for the illness appears to be particularly ineffective, eliciting lower understandability and informativeness ratings. We provide additional evidence in terms of the efficacy of certain metaphors in the linguistic analysis section below. Overall, however, the explicit ratings data indicate that people’s evaluations of the messages were only slightly impacted by the presence of a metaphor. For most of the comparisons, participants tended to perceive the metaphor-enriched messages as similarly understandable, persuasive, and informative as the messages that did not include an extended explanatory metaphor.

c. The interpretation of the ratings of the 5 questions is presented as a conclusion in the abstract. Last sentence of abstract and page 35, line 677: “(2) Metaphors neither enhance nor reduce this effect relative to comparable literal passages.” Given the significant differences in ratings between the metaphor and literal messages, this conclusion is incorrect and warrants revision in line with the suggested revisions to section 3.2.

***Thank you for pointing this out, and again, we apologize for the confusion. The finding referred to in the abstract was not intended to refer to people’s explicit ratings of the stimuli (as described in Section 3.2). Rather, it was intended to refer to the improvement in overall vaccine attitudes, which was similar for those in the literal and metaphor conditions. The abstract included a point about the ratings, however, and we have we now updated it for accuracy and clarity to address the reviewer’s helpful comment:

“Results showed participants in both conditions rated most messages as being similarly understandable, informative, and persuasive, with a few notable exceptions.”

2) In this study, the authors investigated the impact of explanatory metaphors on vaccine attitudes assessed by a Vaccine Attitude Measures tool. A general conclusion was made that “metaphors are comparable to literal passages.” Their conclusion is contradictory to other studies that have shown positive correlations between patient receipt of a vaccine following a conversation with a physician who used a metaphor. This difference in study outcomes was never addressed in the publication and warrants a brief discussion.

****We appreciate this point very much. We don’t believe we can generalize from our study to all other vaccine communication contexts. As we noted in the introduction, there is limited experimental research assessing the efficacy of metaphors on vaccine uptake (though there has been plenty of speculation). The one exception that we are aware of is the set of studies conducted by Scherer and colleagues (2015), which we referenced in our manuscript. Their study was different to ours in a number of key aspects. For example, they used metaphors to describe a specific virus (the flu) rather than to explain how vaccines work. In their first experiment, they found that describing the flu metaphorically as a beast, riot, army, or weed led to increased expressed willingness to be vaccinated compared to describing the flu literally as a virus. Follow-up experiments found mixed evidence that metaphors for the flu impacted requests to receive an e-mail reminder to get vaccinated.

To address the reviewer’s helpful comment, in our updated manuscript, we have elaborated on our discussion of this study in the introduction to better highlight the differences with our research (pages 8-9):

“Describing the influenza virus as a “beast” is quite different from the elaborate explanatory metaphors used in COVID-19 discourse, however. For one thing, “beast” is a metaphor for a virus, rather than a metaphor for some aspect of vaccination. For another, “beast” is a subtle, one-off metaphor rather than an extended and elaborated explanatory metaphor. In contrast, the “Cake” metaphor described above is explicitly presented as an explanation for how researchers could develop the COVID-19 vaccines so quickly, and it was extended and developed throughout the text. It is this latter type of explanatory metaphor that we aimed to evaluate in the present study.”

We have also added to our points on limitations in terms of generalizability in the General Discussion (p. 36):

“Additionally, we did not consider the full set of possible metaphors or uses of metaphor in the context of vaccine communication, which limits the generalizability of our findings. Other research has found that using emotionally-charged metaphors for a virus (e.g., beast, riot, army)—rather than for vaccines—may increase a willingness to get vaccinated, though more research is needed on this topic [33]."

Reviewer #2: I enjoyed this article and learned a lot from the authors’ careful study design and relevant findings. I think that this study would be of great interest to PLOS ONE readers, and I hope to see it published. The study was well designed, and I was especially interested in the original part of the study design that asked participants to “explain it to a friend” and answer vaccine-related questions in their own words. The findings are useful in contributing to a better understanding of how audiences and readers engage different types of vaccine-related information and how information and beliefs and decisions influence one another or not.

***We thank you for the kind words and the deep level of engagement with our paper!

As I wrote above, I was most interested in the findings related to the authors’ method of asking participants to then answer a similar question as if it were posed by a friend. This participatory design -esque angle to vaccine and other forms of public health communication is original and exciting. I was very interested to learn about if and how participants used the metaphors that had just been modeled for them, and I wanted to read more about the ways that participants, when asked to take the reigns and answer this question for a hypothetical friend, improvised their own forms of vaccine communication. Thinking about Covid vaccination learnings, we learned that one of the biggest indicators that someone would be vaccinated against Covid was how many people they knew who were vaccinated. This correlation suggests that people are influenced a lot by those around them and suggests that lay vaccine communicators might have a lot to teach us about vaccination communication! I would look forward to reading an article about these findings and their implications.

***We are most gratified that you appreciated this unique aspect of our methods, and we agree this is a critical and fascinating topic to investigate further. A full treatment along these lines was sadly outside the word limit and scope of the current manuscript, as we wanted to focus mainly on developing and assessing the impact of various explanatory metaphors. As we discuss more below, we view the current study as a first step in a much broader and more expansive project aimed at improving communications surrounding vaccines and vaccine uptake, and the reviewer’s comments have been extremely helpful to us in this respect, so again, thank you.

I did have a few smaller suggestions that I think would help the article (1) better engage with vaccine-related scholarship and (2) clear up a few confusions I had about the study’s methods.

LITERATURE REVIEW

This comment isn’t one that I think absolutely needs to be addressed, but I did want to note that I wished the authors had addressed the growing body of work that investigates why people believe the things they believe about vaccines - i.e., the people the research team is trying and persuade with these metaphors.

I was wary that the authors avoided any reference to scholarship in the social sciences and humanities that has examined how people come to their vaccine beliefs and has largely concluded that deficit-based messaging approaches to vaccine communication and persuasion don’t work very well. Research shows us that, in short, the assumption that people are vaccine hesitant because of ignorance or misinformation and that their beliefs can be “corrected” by delivering persuasive and accurate information is limited. Instead, vaccine beliefs are complicated, fluid, and inextricable from their specific, social situations and histories. Changing vaccine hesitancy involves building trusted, long-term relationships with individuals and communities, not necessarily trying to package the right message and find the right messenger. Here I’m thinking of work by Bernice Hausman, Elena Conis, Nicole Charles, JEnnifer Reich, Maya Goldenberg, Heidi Lawrence, Melissa Leach & James Fairhead, Clare Decoteau, and Andrea Kitta.

I’ll add that this broader more contextualized approach to vaccine hesitancy as a complex social problem rather than a problem of individuals who believe the wrong things came, briefly, into mainstream vaccine discourse during the phased distribution of Covid vaccines, a time when there was a lot of talk about how and why, for example, people without health insurance might be vaccine hesitant because they don’t trust the systems that produce vaccines to look out for them (and not because they don’t understand or trust the vaccine, specifically), or why Americans of color would be skeptical of the US healthcare system and hold off on signing up for a new vaccine.

This isn’t to say that studies focused on questions about effective messaging don’t have a place – as I’ve written in the rest of the review, I think there’s so much of value in this study – but especially in a study that is attuned to audience and learning how targeted audience members make sense of and are or are not changed by a message, I would love to see, in the literature review sections, acknowledgement of the humanistic and social science work out there that is investigating and producing really important findings about how people come to their health beliefs and decisions.

***We agree that the insights provided by this body of work are critical. Again, while a full treatment of this literature is beyond the scope of our article, having thought about the reviewer’s perspective, we also agree it is necessary to discuss the broad, complex contours of these issues. In the updated manuscript, we now reference and discuss some of this work in the beginning of the introduction to better situate the contribution and context of our research (p. 3-4):

“Vaccine hesitancy is a complex phenomenon [2]. It has been associated with many factors, including age, education, mistrust in institutions, engaging with misleading sources online, local and sometimes vaccine-specific personal/family histories [3], and ‘folkloric narratives’ [4–8]. A 2014 WHO report from the Strategic Advisory Group of Experts on Immunization (SAGE) includes three categories of determinants of vaccine hesitancy [9]: (a) ‘contextual influences’ (e.g., religion, culture, politics, media environment); (b) ‘individual and group influences’ (e.g., previous experiences with vaccinations by the individual and their kinship and social groups, immunization as a social norm or as not needed or harmful); and (c) ‘vaccine/vaccination-specific issues’ (e.g., new vaccine, mode of administration, cost, risks vs. benefits). Responding to vaccine hesitancy is therefore also a complex enterprise that goes beyond the provision of ‘accurate’ information [10], whether in public health campaigns or in interactions between healthcare providers and individuals. In this context, then, it is clearly important to investigate the utility of different approaches to vaccine-related communications. The current study investigates the effectiveness of explanatory metaphors in public health messaging about vaccination, and their influence on how individuals perceive communicating about different aspects of vaccinations with members of their own social groups.”

As we discuss further below, we have also expanded our General Discussion in a number of places to highlight additional limitations and opportunities for future research that intersect with more interpersonal approaches to vaccine communications.

METHODS

Recruitment

I wanted to know more about the limitations and reasons for using Amazon’s mTurk as a recruitment tool. Obviously it’s easy to recruit participants through this tool, but are there other, more research-driven reasons the authors chose to use mTurk?

In particular, I think the authors should discuss to what extent mTurk participants are a representative group to draw conclusions about general vaccination feelings, beliefs, and persuade-ability. I’m thinking again of all of the great social sciences and humanistic work that argues that real and effective vaccine communication must be built in relationships over time. That is, communicating scientific facts to people–even in culturally specific and artful ways–doesn’t work because this kind of generalized, mass communication rarely addresses people’s actual concerns, which are grounded in their lives, experiences, personal and collective histories, and social networks. So vaccine communication needs to be localized, iterative, and built into broader networks of relationships and trust. By asking mTurk anonymous participants who are likely churning through digital tasks one after another to share a bit about their responses to vaccine messages, the authors are not aligning themselves with this body of research. So I wondered what scholarship the authors are drawing on to endorse learning about vaccine beliefs and changes in belief in this way, that is, in a way that asks people to type a bit about their vaccine decisions made hypothetically, abstracted from all context, and only in hypothetical terms?

The research design – asking people to take assessments about conspiracy beliefs, vaccine beliefs, etc., and using an attention check to select participants more likely to actually read the prompts – all looked great. But I wanted to better understand how, in light of so much research pointing to vaccine decision-making as complex, situational, and tied to specific, local contexts, this method is useful to generate knowledge that *actually* captures how people are making vaccine decisions.

***We appreciate these important and thoughtful points. We used mTurk for several reasons. As you indicated, it makes recruiting a large sample of research participants fast and easy, as well as cost effective. It has also been shown to be a reliable platform for recruiting research subjects who are more diverse than most convenience samples that were available to us (e.g., undergraduate students taking psychology and linguistics courses). Also persuasive in our decision to use the platform is the fact that a number of key findings in the social and behavioral sciences have been successfully replicated there.

While some scholars have highlighted issues with data quality on mTurk, including both inattentive subjects and the presence of bots (i.e., fake participants), we took several steps to ensure our data would be reliable. This includes, as the reviewer mentions, using an attention check question at the start of the study as well as our use of CloudResearch to recruit participants. CloudResearch is an online platform that interfaces with mTurk and uses a variety of validated methods to increase the quality of participants who are recruited to complete each study. Several recent studies have shown that using CloudResearch leads to significantly higher quality data. To make sure this is clearer in the paper, we have added several references and included an expanded discussion of this issue in the limitations section of the General Discussion in the updated manuscript (pages 35-36):

“While this platform is widely used in social science research and has proven to be a reliable sampling resource [52,53], some scholars have recently voiced concerns about the presence of bots and other data quality issues [54]. While we implemented several best practices designed to mitigate these problems (e.g., including an attention check question and using CloudResearch to recruit participants, which pre-screens MTurk users and has been shown to yield higher quality data [36,37]), future work should aim to replicate these findings with alternative populations.”

We also agree with the broader point made – that fully addressing vaccine education and hesitancy will take more than a simple 10-minute online intervention. However, as we noted earlier, we view our current study and manuscript as a first step towards the development of more effective communication tools that could become part of the “localized, iterative” conversations you describe that are “built into broader networks of relationships and trust.” We believe our study represents one cost-effective way to systematically generate and test messages that healthcare workers and everyday citizens might use in these more interpersonal, on the ground, communicative contexts. We have added a brief point to this effect in the General Discussion section in the updated manuscript (p. 37).

I also think the Methods section should address how participants were compensated.

***We have now added compensation information to the Participants section in the updated manuscript (participants were paid $3).

Study design

I wondered about the authors’ choice to use similar metaphors to answer the question “How do vaccines work?” Based on existing scholarship on vaccines and metaphors, both of these metaphors would fall into a category of older commonplace metaphors about bodies, vaccines, and disease–metaphors that see each body as a sealed-off, fortress-like entity that defends itself against outside germs. By contrast, a more contemporary metaphor by which many people understand the body and immunity is that of a complex system (flexible immunity) – the body constantly adapts to its environment and grows stronger through encounters with pathogens and other things, like dirt. (Emily Martin’s work on immunity and immune systems metaphors is foundational here, but other scholarship on vaccination and metaphors has taken up and extended this argument. So, it seems like both of the metaphors here rely on the older model of the body - a discrete self that must be defended - rather than this flexible immunity model. I wonder if the authors can speak to this decision?

***These are excellent points. Our selection of metaphors for all of the questions was guided by the authentic, real-world metaphors we have observed in COVID-19 vaccine discourse over the past few years. For the question of “How do vaccines work?”, we generally observed these sealed-off, fortress-like metaphors. While the “Castle” and “Bank” metaphors have similar entailments because of this shared domain structure, they do differ in other respects that we felt had the potential to impact our results. For example, for fans of fantasy stories like Lord of Rings and Game of Thrones, these metaphors might resonate more than for others. Research suggests that one’s affinity and interest in a metaphorical source domain might affect how deeply one processes a metaphor. Having said this, we fully agree that using an alternative method to generate maximally distinct metaphors is also warranted, and that is precisely what we intend to do in future research. We appreciate the reference to Emily Martin’s work, which looks very promising in this regard. We now include an additional sentence about this in our General Discussion, speaking to the limitations of our metaphor stimuli (p. 36):

“Additionally, we did not consider the full set of possible metaphors or uses of metaphor in the context of vaccine communication, which limits the generalizability of our findings.”

I wondered why the authors didn’t consider race as a demographic feature that influences vaccine decision making and trust in institutions (p. 20, lines 356 - 359)?

***There are a number of reasons for why we did not consider race in our analyses in the current paper. The first is the complexity of the construct, particularly in light of indications that race may be related to vaccine hesitancy for a wide variety of reasons. Participants self-reported their racial identity, and this data turned out to be much more complex than a multiple-choice answer (as you can see if you examine our data file on the Open Science Framework). Since we did not have a priori predictions about how race might interact with our findings, we did not have any clean way of coding this demographic data reliably. Another complication is that race is often confounded with other factors that affect vaccine hesitancy and trust in institutions that we did look at, such as political ideology. In sum, we view race as another important topic for future research that is outside the scope of the current manuscript. We are committed to examining metaphors in non-WEIRD populations in general in our future research.

On p 15 lines 247-8, the authors write “After reading one of the three explanations associated with a particular question, participants were asked to consider how the general public would react to the message and to keep this in mind while responding to four questions.” I didn’t understand why the authors asked the participants to imagine how a general public audience would respond to the persuasive messaging. Isn’t the goal of the study to track how individual participants respond to the messaging? And to see how individuals respond to and are affected by the messages? It seems the participants should be reporting on their own impressions–how easy each participant found a passage to understand, how informative each participant found a passage–and not trying to speak for an imagined, general public audience.

***This is another helpful point from the reviewer. We chose to ask our participants to consider how the general public would react and to keep this in mind to mitigate any reluctance they might have to reveal their own views given the highly emotive and politicized nature of vaccine/booster discourse at the time of the study. As we know from decades of prior research, an audience (or halo) effect arises when a person’s behavior or reports about their own behavior or beliefs change because they believe someone else is watching them. Depersonalizing this and making it a less face-threatening task by asking participants to ostensibly report from a position of how the general public would react, rather than themselves, was a design factor intended to reduce: (a) the audience effect together with (b) any reluctance to go on the record with a personal response with the goal of obtaining more authentic data. We have now included some language to make the reasons behind this choice clear.

Not a point that needs to be addressed, but a possibly generative question I had while reading:

I was interested in how the results about which metaphors were effective and ineffective might reveal more about public understandings of public health more so than the effectiveness of individual metaphors. For example, the metaphors that rely on individualist ideas of health (i.e., do things that maximize your own personal health and minimize risks to your own persona health) were the more clear, salient, and effective metaphors (e.g., Bank metaphor, Castle metaphor, Raincoat metaphor) And the metaphors that asked audiences to think about health as an interdependent, community state, one in which we should make decisions toward a greater social good fell flat (the war metaphor). Do these findings suggest that specific metaphors themselves were more or less clear or do they suggest that metaphors, arguments, policies, etc that align with individualist notions of health make more sense than metaphors, arguments, polities, etc that align with collective approaches to health?

***We thank the reviewer for this very interesting point. We have added this possibility to the Limitations section in the General Discussion and included a reference to a recent study that contrasts the effects of information about personal vs. collective benefits of vaccinations during the Covid-19 pandemic (p. 37):

“Future work could also usefully consider differences in responses to metaphor depending on whether they emphasize the benefits of vaccination for the individual (e.g., Castle, Bank, Raincoat and Seatbelt metaphors) vs. benefit for others (e.g., Speed Limits and War metaphors). For example, a randomized control trial on the effects on U.K. adults of different types of vaccine information strategies during the COVID-19 pandemic found that, for strongly vaccine hesitant participants, information about the personal benefit of vaccination reduces hesitancy to a greater extent than information about collective benefits [55].”

Sentence-level points

Is there a reason to use the word “Interestingly” on p 3 line 53? And “presciently”? (Global vaccine hesitancy was already a big problem in 2019, so more accurate than prescient, I would say).

***We agree with this point and have edited these sentences accordingly (p. 3):

“This was not a surprise for some observers. The World Health Organization (WHO) had named ‘vaccine hesitancy’ one of the top threats to global health in 2019 [1], months before the pandemic would take hold.”

Typo on p 4 line 87

***Thank you, we have now corrected this typo.

I had trouble following the last 2 analytical sentences of the section “1.2. Explanatory metaphors in vaccine discourse” (on p. 8, lines 150 -6)

***We apologize for the confusion. We have now edited these sentences for clarity (pp. 8–9):

“Describing the influenza virus as a “beast” is quite different from the elaborate explanatory metaphors used in COVID-19 discourse, however. For one thing, “beast” is a metaphor for a virus, rather than a metaphor for some aspect of vaccination. For another, “beast” is a subtle, one-off metaphor rather than an extended and elaborated explanatory metaphor. In contrast, the “Cake” metaphor described above is explicitly presented as an explanation for how researchers could develop the COVID-19 vaccines so quickly, and it was extended and developed throughout the text. It is this latter type of explanatory metaphor that we aimed to evaluate in the present study.”

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Kari Campeau

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Wojciech Trzebiński

17 Aug 2023

PONE-D-23-09747R1Seatbelts and raincoats, or banks and castles: Investigating the impact of vaccine metaphorsPLOS ONE

Dear Dr. Flusberg,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for improving the manuscript. In this round, two additional reviewers provided minor comments that should be fixed. On top of that, my comments are: (1) please use the singular form “between-subject” instead of “between-subjects,” (2) please provide p-values or at least the indication of the statistical significance of the differences in Table 4 (that was also asked by one of the Reviewers in the previous round), (3) when mentioning one-way ANOVA, please explicitly state what the factor (independent variable) is, (4) why you do not provide comparisons between two conditions that constitute your experimental design (i.e., metaphor vs. literal), as you declared (rows 188-189), (5) when reporting p-values on p. 20, please also report the means and test statistics.

Please submit your revised manuscript by Oct 01 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wojciech Trzebiński, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #3: As a "second-round" reviewer I would like to acknowledge that the authors answered to the concerns and question raised by previous reviewers and add that: 1) (lines 156-157) literature on the impact of metaphorical framing on vaccine attitudes is not limited to Scherer and colleagues 2015 (see Ervas et al. 2022); 2) (question 4; metaphor 2 WAR) "With certain viruses, some people who get infected can experience" --> the word "can" is added, when compared to the other texts, with no apparent reason. In general, the texts (especially in the "literal version") are not well-balanced: the literal version is always shorter than the other versions and this might influence the ease and times for comprehension.

Reviewer #4: This paper describes a very interesting study with a sound methodology and relevant findings for the examined field (which also provide useful insights into aspects of metaphor use that go beyond the main purpose of the study itself). For instance, some inputs are given as to which specific aspects of vaccination can be successfully explained through metaphor use (e.g., natural immunity vs vaccine immunity). Furthermore, the section with the free-text answers (with some metaphors used incorrectly but with the same conceptual mapping presented in the explanation stimulus, others used correctly but in the attempt to refute the statements presented in the explanation stimulus, others invented by respondents) is also an interesting starting point for future research.

The study limitations (e.g., resorting to only a selection of metaphors available in vaccine campaigns) and previous reviews’ comments (like some remarks concerning methodology, like why respondents needed to state how they thought a general audience would react to certain messages rather than express their own opinion directly – to avoid some sort of “self-censorship” due to the stigmatization of vaccine aversion and hesitancy in an emotive and politicized historical moment like the one right after the coronavirus pandemic) seem to have been addressed properly.

The conclusion is that it is deemed to be highly advisable to publish this paper.

Some (minor) remarks and/or suggestions that may help further improve the paper are the following:

ABSTRACT:

I would mention the denomination “literal responses” a line before. The current formulation may be initially confusing: while reading the abstract, my first thought was that the study was going to examine extended metaphors and non-extended ones (as defined later in the paper - in p. 8, line 167 - “one-off” metaphors). A possible solution would be: “We created three response passages for each question: two included extended explanatory metaphors and one contained a literal response, with no explanatory metaphors”).

MAIN TEXT:

1) In the theoretical framework, when I read the section about extended explanatory metaphors (and their opposition to “one-off” metaphors) I thought about the frequent term “metaphor(ical) scenario” (as in Musolff 2006 or 2016*) with the “mininarratives”. It could be useful to add this terminology in the beginning to clarify what is meant in the text with “extended metaphors”. In case there is no full equivalence between this term and term “extended metaphors” as intended in the study, this could also be explained and motivated.

In addition, the term “metaphorical scenario” does indeed occur randomly in the paper (line 559, with respect to the Video Game metaphor, and line 574, with respect to the Raincoat metaphor), which further convinced me it could be useful to add it in the beginning, too.

N.B.: “scenario” also occurs a third time in line 583, in the segment “in the answers to the friend scenario”. As “scenario” is a technical term in metaphor studies, I would reformulate this part to avoid possible confusion.

2) I find that there are some similarities between some of the metaphors chosen for the study. More specifically, I feel that the Castle metaphor is a subtype of War metaphors (of course, with a different focus, but the mention of words like “invaders”, “defence” etc. seems to support this theory). I find this aspect important for several reasons. Firstly, on the basis of what is stated in the Linguistic Analysis at page 27: “[…] This is consistent with the finding that the War metaphor was perceived as particularly ineffective, as also shown in the ratings data described earlier. This is a particularly interesting finding given the prevalence of war messaging in vaccine discourse, particularly early on in the pandemic”. If the (more effective, “successful”) Castle metaphor is also regarded as a subtype of War metaphors, this once again shows that (although controversial!) war metaphors are quite effective, and this sentence should be modified accordingly.

To differentiate between these two metaphors, maybe a different (more specific, as occurs with Castle) label could be proposed for what is now called War metaphor in the paper survey (in Question 4, Metaphor 2), like Army Enrolment, Army Enlistment, or Mobilization.

Considering the Castle and Army Enrolment metaphors as subtypes belonging to the same source domain may also have an impact on the paper in other ways: as stated at page 24, some metaphors may be especially effective to communicate about some particular aspects of a phenomenon (e.g., Pilots and Fire Drills and a particular issue of natural immunity). If the categorization I put forward is implemented, the importance of choosing the right connection between a specific source and target (sub)domain is also better highlighted. So maybe war metaphors are effective in showing how vaccines work but not as effective in explaining the concept of herd immunity. This different effectiveness can also be explained through one of the variables reported in Table 1 at page 5 (army mobilization, unlike castle defence systems, is not very straightforward to many people! I also found this extended explanatory metaphor quite hard to follow as I first read it).

3) I think that the use of the rhetorical question “Would you rather wear a raincoat or walk around unprotected during a thunderstorm?” at page 31 should be highlighted, as it shows some sort of emotional involvement on part of the participant, which proves that this metaphor is effective.

TYPOS:

p. 19, line 326: five response questions (I guess!)

p. 20, line 359: explicit

p. 25, line 452: abstract

p. 29, line 29: “[…] question asked was “How do vaccines work?”. The […]

p. 31, line 577: “raincoat even if” (or, if it was a mistake made by the participant, add [sic]!)

p. 32, line 597: missing full stop before “finally”

p. 32, line 604: (92106; 100% re-user) --> I think this parenthesis was not meant to be here, maybe it was a note/reference meant only for the authors which “slipped in” during writing. If this is not the case, it is not clear what this number refers to.

p. 36, line 688: there seems to be a missing space before “relatedly”

p. 37, line 711: after both occurrences of e.g. the comma is underlined

SOME POTENTIAL TYPOS/POINTS WITH POTENTIAL STYLISTIC IMPROVEMENTS:

Consider that I am not a native speaker of English, so these are some points that can be ignored by the authors if necessary:

p. 4, line 74: The seminal work […]?

p. 31, line 591: metaphor use? Or used?

p. 36, line 697: willingness/ the willingness to get vaccinated?

OTHER TYPOGRAPHICAL INDICATIONS:

I recommend being more typographically consistent in the way metaphors are reported. For instance, in the theoretical framework some metaphors are written in italics (beast, riot etc., line 158). In line 697, the same metaphors have a standard font, with no italics. In the introduction, some metaphors are reported between inverted commas (e.g., the “Cake” metaphor, line 168), but then they have a standard font in other parts of the text (e.g., the Bank or Castle metaphor, line 362). Of course, small capitals can be kept as a way to refer to conceptualizations and domains (as occurs in the introduction at page 4, for instance).

Line 662: seven in digits, maybe?

Use of hyphens: in some cases (like page 8, line 162-3, or 184-5) hyphens are longer and words are not separated by a space. In other cases, like at page 34 (line 658) the hyphen is shorter and there is a space that separates it from the words.

Pag. 18, line 313: maybe here the usual indication “[…]” should be used instead of the three dots?

*Musolff A. (2006) “Metaphor scenarios in public discourse”, Metaphor and Symbol, 21:1, pp. 23-38.

Musolff A. (2016) Political metaphor analysis: Discourse and scenarios, Bloomsbury Academic.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Amanda J Chase

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 3;19(1):e0294739. doi: 10.1371/journal.pone.0294739.r004

Author response to Decision Letter 1


29 Sep 2023

All responses to the editor and reviewers is included in the "response to reviewers" document, which we submitted along with our revised manuscript.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Wojciech Trzebiński

18 Oct 2023

PONE-D-23-09747R2Seatbelts and raincoats, or banks and castles: Investigating the impact of vaccine metaphorsPLOS ONE

Dear Dr. Flusberg,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wojciech Trzebiński, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

 I appreciate your improvements, and the reviewers accept your revised manuscript. However, I have one more crucial doubt that needs to be addressed before the acceptance. Namely, one may understand from your Abstract that the only positive result you have consistently reached is that “participants in the metaphor condition provided longer free-response answers to the question posed by a hypothetical friend” (rows 39-41). If so, it is crucial to provide some argument that this difference is statistically significant. In Table 5, you report the “cumulative” word count. If it is a sum of words used by all participants in particular conditions, it depends on the sample sizes. So, it would probably be necessary to calculate the means of the word count per condition. Then, you should compare the means between conditions to check the statistical significance.

Please also double-check the manuscript for typos (e.g., row 566). 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: The authors addressed all my questions/concerns. Thanks for the opportunity to read this piece of reasearch.

Reviewer #4: At this stage of review, I only want to point out a few typos/stylistic suggestions:

War mobilization in italics, lines 526-7

line 632: and not capitalized

line 619-620: and not capitalized twice

We return to this finding (lines 470, 544): I think this could be formulated in a better way stylistically, like "This finding will be further discussed/discussed in greater detail ...etc. "

But see 37 (line 670): I find this could also be expressed in a better way

Posttest is sometimes written with an hyphen, sometimes without it; I do not understand if there is a reason to it

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 3;19(1):e0294739. doi: 10.1371/journal.pone.0294739.r006

Author response to Decision Letter 2


3 Nov 2023

I appreciate your improvements, and the reviewers accept your revised manuscript. However, I have one more crucial doubt that needs to be addressed before the acceptance. Namely, one may understand from your Abstract that the only positive result you have consistently reached is that “participants in the metaphor condition provided longer free-response answers to the question posed by a hypothetical friend” (rows 39-41). If so, it is crucial to provide some argument that this difference is statistically significant. In Table 5, you report the “cumulative” word count. If it is a sum of words used by all participants in particular conditions, it depends on the sample sizes. So, it would probably be necessary to calculate the means of the word count per condition. Then, you should compare the means between conditions to check the statistical significance.

***We appreciate and agree with this suggestion. We have now conducted the appropriate calculations and statistical tests, which we have incorporated into the updated manuscript (pages 27-8). The inferential statistics provide further support for the conclusion presented in the abstract and general discussion: participants in the metaphor condition used significantly more words on average (~18% overall) compared to participants in the literal condition in response to the free text “explain to a friend” prompt across all the questions.

***We have expanded Table 5 in this section of the paper to provide more descriptive data about the mean word counts for each question and condition. All our in-text discussion of these findings, as well as a revised Figure 3, now present the mean rather than cumulative word count data. We feel that presenting the data in this way and making these changes has strengthened this section of the paper as well as our overall conclusions.

***Of note, while conducting these new analyses we discovered a single numerical error in our earlier manuscript. Specifically, we had under-reported the cumulative word count in the free text response for the war metaphor passage in response to Question 4. This appears to have been a random transcription error as we compiled the original manuscript, as an early version of the table we created included the correct number. This error is minor and only served to weaken our original conclusions. We have corrected the error and modified our discussion accordingly. We now have even stronger evidence to support our conclusion that participants who received a metaphorical passage used more words in their “explain to a friend” free text responses.

***Considering all this, however, we took this opportunity to double check all the analyses and values reported throughout the paper (in figures and text) to ensure accuracy. We discovered no other errors in the manuscript, so we are confident in the accuracy of our reporting. In the spirit of transparency, our raw data is accessible via an updated, now public link to the Open Science Framework.

Please also double-check the manuscript for typos (e.g., row 566).

***We have now double-checked the manuscript for typos and other typographical errors and believe everything is in order.

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: The authors addressed all my questions/concerns. Thanks for the opportunity to read this piece of research.

Reviewer #4: At this stage of review, I only want to point out a few typos/stylistic suggestions:

War mobilization in italics, lines 526-7

line 632: and not capitalized

line 619-620: and not capitalized twice

We return to this finding (lines 470, 544): I think this could be formulated in a better way stylistically, like "This finding will be further discussed/discussed in greater detail ...etc. "

But see 37 (line 670): I find this could also be expressed in a better way

Posttest is sometimes written with an hyphen, sometimes without it; I do not understand if there is a reason to it

***We have addressed all these issues in the revised manuscript.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 3

Wojciech Trzebiński

8 Nov 2023

Seatbelts and raincoats, or banks and castles: Investigating the impact of vaccine metaphors

PONE-D-23-09747R3

Dear Dr. Flusberg,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wojciech Trzebiński, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for further improving your manuscript, especially in terms of statistical analysis. 

Minor issue to be fixed with the editorial team: at the oend of line 565, there is still an unnecessary quotation mark to be removed.

Reviewers' comments:

Acceptance letter

Wojciech Trzebiński

13 Dec 2023

PONE-D-23-09747R3

PLOS ONE

Dear Dr. Flusberg,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Wojciech Trzebiński

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    Data are publicly available on the Open Science Framework at the following link: https://osf.io/jg9st/.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES